Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Aberer Werner |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Till, H
Pyelumdilations, hydrocoeles and undescended testes.
10th Congress of the European Academy of Paediatric Societies; OCT 18-20,2024; Vienna, AUSTRIA. 2024.
[Oral Communication]
Arzt-Gradwohl, L; Herzog, SA; Aberer, W; Arias, TA; Antolin-Amerigo, D; Bonadonna, P; Boni, E; Bozek, A; Chelminska, M; Ernst, B; Frelih, N; Gawlik, R; Akkor, A; Hawranek, T; Hoetzenecker, W; Blanco, MAJ; Kita, K; Kendirlinan, R; Kosnik, M; Laipold, K; Lang, R; Marchi, F; Mauro, M; Nittner-Marszalska, M; Poziomkowska-Gesicka, I; Pravettoni, V; Preziosi, D; Quercia, O; Reider, N; Rosiek-Biegus, M; Ruiz-Leon, B; Schrautzer, C; Serrano, P; Sin, AZ; Sin, BA; Stoevesandt, J; Trautmann, A; Vachová, M; Sturm, G
Safety and effectiveness of venom immunotherapy: Evaluation of premedication and venom preparations
ALLERGY. 2023; 78:
[Poster]
Web of Science
FullText
Schöffl, C; Cerpes, U; Koch, L; Aberer, W
Transitioning from insufficient acute therapy and prophylaxis to effective disease control in HAE using lanadelumab
ÖGDV Jahrestagung; NOV 30-DEZ 02, 2023; Salzburg, AUSTRIA. 2023.
[Poster]
FullText
Schöffl, C; Koch, L; Aberer, W
Moving from inadequate acute treatment and prophylaxis to successfull management with lanadelumab
HAE EMEA Conference 2023; SEP 1-3, 2023; München, GER. 2023.
[Poster]
Grims, RH
Anaphylaxie auf pflanzliche Allergene, Beispiel: Brennnesseltee
14. Wörthersee Symposium
; MAY 13-14, 2022; Velden am Wörthersee, AUSTRIA. 2022.
[Oral Communication]
De Kam, PJ; Aberer, W; Kuna, P; Bjermer, L; Berger, U; Seybold, M; Ernst, A; Lis, K; Skinner, MA
Safety and immunology results from a pivotal phase III study with a modified birch SCIT product
ALLERGY. 2021; 76: 33-33.
[Oral Communication]
Web of Science
Koch, L; Laipold, K; Arzt-Gradwohl, L; Cerpes, U; Sturm, E; Aberer, W; Sturm, G
Component-resolved diagnosis of IgE-mediated allergy to seasonal inhalant
allergens is sensitive and may facilitate in-vitro diagnosis
Abstracts Book DocDay 2021. 2021; -DocDay 2021; FEB 12, 2021; Graz, AUSTRIA.
[Onlinepräsentation]
FullText
Prinz, F; Reicher, A; Klec, C; Jonas, K; Posch, F; Pichler, M
miRNA mimics can artificially influence the expression of immune checkpoint molecules in biliary tract cancer.
Doctoral Day - Medical University of Graz; FEB 12, 2021; Graz, AUSTRIA. 2021.
[Onlinepräsentation]
Schöffl, C; Haas, A; Aberer, W
Functional C1-INH determination: influence of temperature, time and sample handling
HAE Connect 2020-2021 Global Forum; Dec 2020- Nov 2021; Lexington, MA, USA;. 2021.
[Poster]
Schrautzer, C; Arzt-Gradwohl, L; Bokanovic, D; Schwarz, I; Cerpes, U; Koch, L; Herzog, SA; Laipold, K; Binder, B; Aberer, W; Sturm GJ
A safe and efficient 7-week immunotherapy protocol with aluminum hydroxide adsorbed vespid venom
WVSD-Jahrestagung; JUN 6, 2021; Graz, AUSTRIA. 2021.
[Oral Communication]
Arzt-Gradwohl, L; Sturm, G; Herzog, SA; Aberer, W; Alfaya Arias, T; Antolín-Amérigo, D; Bonadonna, P; Boni, E; Bozek, A; Chelminska, M; Ernst, B; Frelih, N; Gawlik, R; Gelincik, A; Hawranek, T; Hötzenecker, W; Jimenez Blanco, A; Kita, K; Kendirlinan, R; Košnik, M; Laipold, K; Lang, R; Marchi, F; Mauro, M; Nittner-Marszalska, M; Poziomkowska-Gesicka, I; Pravettoni, V; Preziosi, D; Quercia, O; Reider, N; Rosiek-Biegus, M; Ruiz-Leon, B; Schrautzer, C; Serrano, P; Sin, A; Sin, BA; Stoevesandt, J; Trautmann, A; Vachova, M
No effect of antihypertensive drugs on severity of anaphylaxis and adverse events during venom immunotherapy.
Allergo J Int 2020;. 2020; 29: 248-255.-12th Symposium of the Working Group on Insect Venom Allergy; NOV 20-21, 2020; Frankfurt, GERMANY.
[Oral Communication]
Caballero, T; Maurer, M; Longhurst, HJ; Bouillet, L; Grumach, AS; Botha, J; Andresen, I; Aberer, W
Effectiveness of icatibant to control symptoms of HAE attacks in real-world clinical practice.
ALLERGY. 2020; 75: 206-207.-European-Academy-of-Allergology-and-Clinical-Immunology Digital Congress (EAACI); JUN 06-08, 2020; London, ENGLAND.
[Oral Communication]
Web of Science
Koch, L; Laipold, K; Arzt-Gradwohl, L; Cerpes, U; Sturm, EM; Aberer, W; Sturm, GJ
IgE multiplex testing in house dust mite allergy is utile and sensitivity is comparable to extract-based singleplex testing.
Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI); JUN 6-8, 2020; London, ENGLAND. 2020.
[Onlinepräsentation]
Koch, L; Laipold, K; Arzt-Gradwohl, L; Cerpes, U; Sturm, EM; Aberer, W; Sturm, GJ
IgE multiplex testing in house dust mite allergy is utile and sensitivity is comparable to extract-based singleplex testing.
ALLERGY. 2020; 75: 159-159.-European-Academy-of-Allergology-and-Clinical-Immunology Digital Congress (EAACI); JUN 06-08, 2020; London, ENGLAND.
[Poster]
Web of Science
Longhurst, HJ; Bouillet, L; Aberer, W; Caballero, T; Grumach, AS; Botha, J; Andresen, I; Maurer, M
Treatment of acute attacks of hereditary angioedema due to C1 inhibitor deficiency with icatibant in paediatric versus adult patients: Findings from the icatibant outcome survey.
ALLERGY. 2020; 75: 209-209.-European-Academy-of-Allergology-and-Clinical-Immunology Digital Congress (EAACI); JUN 06-08, 2020; London, ENGLAND.
[Oral Communication]
Web of Science
Maurer, M; Longhurst, HJ; Bouillet, L; Caballero, T; Grumach, AS; Botha, J; Andresen, I; Aberer, W
Long-term effectiveness and safety of icatibant for the on-demand treatment of hereditary angioedema attacks: 10 years of the Icatibant Outcome Survey.
ALLERGY. 2020; 75: 59-60.-European-Academy-of-Allergology-and-Clinical-Immunology Digital Congress (EAACI); JUN 06-08, 2020; London, ENGLAND.
[Oral Communication]
Web of Science
Schöffl, C; Haas, A; Aberer, W
HAE - the crux with C1-INH testing in everyday lab work.
ÖGDV Jahrestagung 2020; DEC 3-5, 2020; Vienna, Austria. 2020.
[Poster]
Andresen, I; Longhurst, H; Aberer, W; Bouillet, L; Caballero, T; Grumach, AS; Maurer, M; Botha, J; Zanichelli, A
Icatibant Treatment of Acute Attacks in Pediatric Patients With Hereditary Angioedema: Findings from the Icatibant Outcome Survey
J ALLERGY CLIN IMMUN. 2019; 143(2):AB44-AB44.-Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI); FEB 22-25, 2019; San Francisco, CA.
[Poster]
Web of Science
Ballard, R; Zielen, S; Aberer, W; Lassmann, S; Wade, A; Kluehr, K; Raab, J; Lee, D; Jones, C; Gunawardena, K; Kramer, M; Skinner, MA; Higenbottam, T
Strong Dose-response Using a Conjunctival Provocation Test During a Phase II Allergen Immunotherapy Study With Subcutaneously Administered Tyrosine Adsorbed Modified Grass Allergen plus MPL
J ALLERGY CLIN IMMUN. 2019; 143(2):AB285-AB285.-Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI); FEB 22-25, 2019; San Francisco, CA.
Doi: 10.1016/j.jaci.2018.12.871
[Poster]
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
Farkas, H; Ortega-Lopez, MC; Reshef, A; Kessel, A; Caballero, T; Vardi, M; Hao, J; Aberer, W
Early treatment with icatibant reduces the time to onset of symptom relief in children and adolescents with hereditary angioedema (HAE)
ALLERGY. 2019; 74: 210-211.-Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI); JUN 01-05, 2019; Lisbon, PORTUGAL.
[Oral Communication]
Web of Science
Kessel, A; Farkas, H; Reshef, A; Caballero, T; Ortega-Lopez, MC; Vardi, M; Hao, J; Aberer, W
Rapid and sustainable effect of icatibant across recurrent hereditary angioedema attacks in adolescent patients
ALLERGY. 2019; 74: 213-214.-Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI); JUN 01-05, 2019; Lisbon, PORTUGAL.
[Poster]
Web of Science
Lassmann, S; Lee, D; Zielen, S; Aberer, W; Wade, A; Kluehr, K; Raab, J; Ballard, R; Jones, C; Gunawardena, K; Kramer, M; Skinner, MA
Strong Dose-response On Immunoglobulin Makers During a Phase II Allergen Immunotherapy Study With Subcutaneously Administered Tyrosine Adsorbed Modified Grass Allergen plus MPL
J ALLERGY CLIN IMMUN. 2019; 143(2):AB306-AB306.-Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI); FEB 22-25, 2019; San Francisco, CA.
Doi: 10.1016/j.jaci.2018.12.932
[Poster]
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
Longhurst, H; Moldovan, D; Bygum, A; Cicardi, M; Huissoon, A; Aygoren-Pursun, E; Grivcheva-Panovska, V; Hagin, D; Steiner, U; Stobiecki, M; Aberer, W; Bethune, C; Faust, SN; Kiani, S; Launay, D; Maurer, M; Rae, W; Reshef, A; Cornpropst, MT; Dobo, SM; VanDyke, S; Murray, S; Collis, PJ; Sheridan, WP; Farkas, H
Oral Plasma Kallikrein Inhibitor BCX7353 is Safe and Effective as an On-Demand Treatment of Angioedema Attacks in Hereditary Angioedema (HAE) Patients: Results of the ZENITH-1 Trial
J ALLERGY CLIN IMMUN. 2019; 143(2):AB37-AB37.-Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI); FEB 22-25, 2019; San Francisco, CA.
[Oral Communication]
Web of Science
Longhurst, HJ; Caballero, T; Aberer, W; Bouillet, L; Grumach, AS; Botha, J; Andresen, I; Maurer, M
Treatment outcomes with high frequency versus low frequency icatibant use in the real-world setting: Results from the icatibant outcome survey
ALLERGY. 2019; 74: 213-213.-Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI); JUN 01-05, 2019; Lisbon, PORTUGAL.
[Poster]
Web of Science
Longhurst, HJ; Stobiecki, M; Zanichelli, A; Huissoon, A; Moldovan, D; Maurer, M; Magerl, M; Cancian, M; Senter, R; Manson, A; Aygoren-Pursun, E; Grivcheva-Panovska, V; Hagin, D; Steiner, U; Kiani-Alikhan, S; Agmon-Levin, N; Bygum, A; Aberer, W; Faust, SN; Launay, D; Gompels, M; Triggiani, M; Bethune, C; Reshef, A; Cornpropst, M; Dobo, S; Van Dyke, S; Murray, S; Collis, P; Sheridan, WP; Farkas, H; Cicardi, M
Final results from the ZENITH-1 study: Oral administration of plasma kallikrein inhibitor BCX7353 for the treatment of attacks in patients with hereditary angioedema
ALLERGY. 2019; 74: 10-11.-Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI); JUN 01-05, 2019; Lisbon, PORTUGAL.
[Poster]
Web of Science
Schöffl, C; Wiednig, M; Koch, L; Aberer, W
First experiences with the monoclonal antibody lanadelumab for long-term prophylaxis in Austrian hereditary angioedema patients.
ÖGDV Jahrestagung 2019; DEZ 5-7, 2019; Vienna, AUSTRIA. 2019.
[Poster]
Schöffl, C; Wiednig, M; Koch, L; Aberer,W
First real-world data on the use of lanadelumab for prophylaxis in
Austrian HAE-patients.
HAE Global Forum; NOV 14-16, 2019; Berlin, Germany. 2019.
[Poster]
Schrautzer, C; Arzt-Gradwohl. L; Bokanovic, D; Schwarz, I; Čerpes, U; Koch, L; Herzog, SA; Laipold, K; Binder, B; Aberer, W; Sturm, GJ
Efficacy and safety of an accelerated outpatient protocol for wasp venom immunotherapy.
Allergy School on Insect Venom Allergy and Mastocytosis
; APR 11-13, 2019; Groningen, NETHERLANDS. 2019.
[Oral Communication]
Zielen, S; Aberer, W; Lassmann, S; Wade, A; Kluehr, K; Raab, J; Lee, D; Ballard, R; Jones, C; Gunawardena, K; Kramer, MF; Skinner, MA; Higenbottam, T; De Kam, P
Strong dose-response using a conjunctival provocation test during a phase II allergen immunotherapy study with subcutaneously administered tyrosine adsorbed modified grass allergen plus MPL
ALLERGY. 2019; 74: 78-78.-Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI); JUN 01-05, 2019; Lisbon, PORTUGAL.
[Poster]
Web of Science
Zielen, S; Aberer, W; Lassmann, S; Wade, A; Kluehr, K; Raab, J; Lee, D; Ballard, R; Jones, C; Gunawardena, K; Kramer, MF; Skinner, MA; Hingebottam, T; De Kam, P
Strong dose-response on immunoglobulin markers during a phase II allergen immunotherapy study with subcutaneously administered tyrosine adsorbed modified grass allergen plus MPL
ALLERGY. 2019; 74: 686-686.-Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI); JUN 01-05, 2019; Lisbon, PORTUGAL.
[Poster]
Web of Science
Zielen, S; Kuna, P; Aberer, W; Lassmann, S; Wade, A; Kluehr, K; Raab, J; Lee, D; Ballard, R; Skinner, MA; De Kam, P
No correlation between conjunctival provocation test and immune globulins in a positive phase II allergen immunotherapy study with subcutaneously administered tyrosine adsorbed modified grass allergen
ALLERGY. 2019; 74: 681-681.-Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI); JUN 01-05, 2019; Lisbon, PORTUGAL.
[Poster]
Web of Science
Aberer, W; Kuna, P; Bjermer, L; Pfaar, O; Zielen, S; Berger, U; Lee, D; Seybold, M; Ernst, A; Clausen, A; Lis, K; Wittmann, A; Gunawardena, K; Skinner, MA; Higenbottam, T
Design of a pivotal phase III allergen immunotherapy study to assess the efficacy and safety of subcutaneously administered tyrosine adsorbed modified birch allergen plus MPL
ALLERGY. 2018; 73: 629-630.-Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI); MAY 26-30, 2018; Munich, GERMANY.
[Poster]
Web of Science
Andresen, I; Longhurst, HJ; Bouillet, L; Caballero, T; Zanichelli, A; Maurer, M; Grumach, AS; Bygum, A; Botha, J; Aberer, W
Characterization Of Hereditary Angioedema Attacks Requiring Reinjection Of Icatibant: Findings From The Icatibant Outcome Survey
J ALLERGY CLIN IMMUN. 2018; 141(2):AB53-AB53.-American-Academy-of-Allergy-Asthma-and-Immunology / World-Allergy-Organization Joint Congress; MAR 02-08, 2018; Orlando, FL.
Doi: 10.1016/j.jaci.2017.12.170
[Oral Communication]
Web of Science
FullText
FullText_MUG
Coenraads, P; Aberer, W; Cristaudo, A; Diepgen, T; Holden, C; Koch, L; Schuttelaar, M; Weisshaar, E; Fuchs, A; Schlottmann, K; Goebel, C; Blömeke, B; Krasteva, M
The allergy alert test: Introduction of a protocol suitable to provide an alert signal to hair dye users with hair dye allergy.
Contact Dermatitis Journal. 2018; 79s1: 52--ESCD 2018; OCT 17-20, 2018; Milano, ITALY.
[Oral Communication]
Koch, L; Laipold, K; Schrautzer, C; Arzt, L; Cerpes, U; Sturm, EM; Aberer, W; Binder, B; Sturm, GJ
Comparison of sIgE levels to mite extracts and allergen components between asthmatic and non-asthmatic house dust mite allergic patients
ALLERGY. 2018; 73: 551-551.-Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI); MAY 26-30, 2018; Munich, GERMANY.
[Poster]
Web of Science
Koch, L; Laipold, K; Schrautzer, C; Arzt, L; Cerpes, U; Sturm, EM; Aberer, W; Binder, B; Sturm, GJ
Comparison of molecular singleplex and multiplex analysis in the diagnosis of house dust mite allergy
ALLERGY. 2018; 73: 191-192.-Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI); MAY 26-30, 2018; Munich, GERMANY.
[Poster]
Web of Science
Magerl, M; Rae, W; Aygoren-Pursun, E; Bygum, A; Panovska, VG; Steiner, UC; Huissoon, A; Longhurst, H; Cicardi, M; Zanichelli, A; Triggiani, M; Fain, O; Lleonart, R; Katelaris, C; Aberer, W; Kinaciyan, T; Fang, L; Murray, S; Clemons, D; Joseph, K; Sheridan, W; Dobo, S; Collis, P; Cornpropst, M; Weller, K; Maurer, M
BCX7353 improves health-related quality of life in hereditary angioedema with C1-inhibitor deficiency (C1-INH-HAE): Findings from the APeX-1 study
ALLERGY. 2018; 73: 724-724.-Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI); MAY 26-30, 2018; Munich, GERMANY.
[Poster]
Web of Science
Schöffl, C; Wiednig, M; Koch, L; Aberer, W
First-ever survey on the prevalence, epidemiology and distribution of HAE patients in Austria.
HAE Global Conference; MAY 17-20, 2018; Vienna, AUSTRIA. 2018.
[Poster]
Schrautzer C; Arzt L; Koch L; Cerpes U; Herzog S; Binder B; Aberer W; Sturm GJ
The accelerated 7-week outpatient protocol for wasp venom immunotherapy
is safe and effective
AllergyVolume 73, Issue S105. 2018; -EAACI (European Academy of Allergy and Clinical Immunology) Congress; MAY 27, 2018; Munich, GERMANY.
[Poster]
Schrautzer C; Arzt L; Koch L; Cerpes U; Herzog S; Binder B; Aberer W; Sturm GJ
Das ambulante 7-Wochen-Schema in der Wespengift-Immuntherapie.
Klausur AG Allergologie; JAN 03, 2018; Elixhausen, AUSTRIA. 2018.
[Oral Communication]
Zanichelli, A; Maurer, M; Aberer, W; Caballero, T; Bouillet, L; Bygum, A; Grumach, AS; Botha, J; Andresen, I; Longhurst, HJ
Early vs late administration of icatibant in patients with hereditary angioedema
ALLERGY. 2018; 73: 721-722.-Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI); MAY 26-30, 2018; Munich, GERMANY.
[Oral Communication]
Web of Science
Zanichelli, A; Maurer, M; Aberer, W; Caballero, T; Bouillet, L; Bygum, A; Grumach, AS; Botha, J; Andresen, I; Longhurst, HJ
Early Versus Late Administration of Icatibant in Patients With Hereditary Angioedema
SWISS MED WKLY. 2018; 148: 24S-24S.
[Oral Communication]
Web of Science
Zielen, S; Kuna, P; Aberer, W; Lassmann, S; Wade, A; Kluehr, K; Raab, J; Lee, D; Ballard, R; Jones, C; Gunawardena, K; Skinner, MA; Higenbottam, T
Design of a phase II allergen immunotherapy study to determine the optimally effective and safe dose of subcutaneously administered tyrosine adsorbed modified grass allergen plus MPL
ALLERGY. 2018; 73: 487-488.-Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI); MAY 26-30, 2018; Munich, GERMANY.
[Oral Communication]
Web of Science
Arzt, L; Bokanovic, D; Schrautzer, C;Schwarz, I; Laipold, K; Aberer, W; Sturm, GJ
Questionable benefit of the commercially available panel of bee venom components in the diagnosis of bee venom allergy
ALLERGY. 2017; 72: 682-683.-Congress of the European-Academy-of-Allergy-and-Clinical-Immunology; JUN 17-21, 2017; Helsinki, FINLAND.
[Poster]
Web of Science
Aygoren, E; Bygum, A; Steiner, U; Magerl, M; Panovska, VG; Farkas, H; Huissoon, A; Graff, J; Lleonart, R; Rae, W; Aberer, W; Longhurst, H; Smith, W; Zanichelli, A; Cancian, M; Guilarte, M; Triggiani, M; Gompels, M; Fang, L; Cornpropst, M; Clemons, D; Collis, P; Dobo, S; Sheridan, WP; Maurer, M; Cicardi, M
BCX7353, a once-daily oral kallikrein inhibitor, is effective and safe in the prophylaxis of acute attacks in patients with hereditary angioedema: Attack-level analysis of the APeX-1 study
ALLERGY. 2017; 72: 584-585.-Congress of the European-Academy-of-Allergy-and-Clinical-Immunology; JUN 17-21, 2017; Helsinki, FINLAND.
[Poster]
Web of Science
Bokanovic, D; Schrautzer, C; Schwarz, I; Laipold, K; Wutte, N; Aberer, W; Sturm, GJ
Is the skin prick test sufficient to diagnose vespid venom allergy?
ALLERGY. 2017; 72: 677-677.-Congress of the European-Academy-of-Allergy-and-Clinical-Immunology; JUN 17-21, 2017; Helsinki, FINLAND.
[Poster]
Web of Science
Longhurst, HJ; Bouillet, L; Aberer, W; Caballero, T; Grumach, AS; Maurer, M; Zanichelli, A; Bygum, A; Pommie, C; Andresen, I
Elderly vs younger patients (pts) with hereditary angioedema type I/II: safety analysis from the icatibant outcomes survey
ALLERGY. 2017; 72: 593-594.-Congress of the European-Academy-of-Allergy-and-Clinical-Immunology; JUN 17-21, 2017; Helsinki, FINLAND.
[Poster]
Web of Science
Maurer, M; Aberer, W; Caballero, T; Bouillet, L; Longhurst, HJ; Zanichelli, A; Bygum, A; Grumach, AS; Perrin, A; Andresen, I
Early Versus Late Administration of Icatibant in Patients With Hereditary Angioedema
J ALLERGY CLIN IMMUN. 2017; 139(2):AB233-AB233.-Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI); MAR 03-16, 2017; Atlanta, GA.
Doi: 10.1016/j.jaci.2016.12.749
[Poster]
Web of Science
FullText
FullText_MUG
Maurer, M; Caballero, T; Aberer, W; Zanichelli, A; Bouillet, L; Bygum, A; Grumach, AS; Pommie, C; Andresen, I; Longhurst, HJ
Longitudinal natural history of patients with type I or II hereditary angioedema: data from the icatibant outcome survey
ALLERGY. 2017; 72: 99-99.-Congress of the European-Academy-of-Allergy-and-Clinical-Immunology; JUN 17-21, 2017; Helsinki, FINLAND.
[Poster]
Web of Science
Maurer, M; Caballero, T; Bouillet, L; Aberer, W; Grumach, AS; Longhurst, HJ; Zanichelli, A; Bygum, A; Pommie, C; Andresen, I
Gender analysis of baseline characteristics and treatment outcomes in patients (pts) with hereditary angioedema type I/II: findings from the icatibant outcomes survey
ALLERGY. 2017; 72: 149-149.-Congress of the European-Academy-of-Allergy-and-Clinical-Immunology; JUN 17-21, 2017; Helsinki, FINLAND.
[Poster]
Web of Science
Schrautzer, C;Arzt, L; Bokanovic, D; Schwarz, I;Laipold, K;Aberer, W;Sturm; GJ
Questionable diagnostic benefit of the commercially available panel of bee venom components
11.Arbeitsgespräch Insektengiftallergie; MAY 19-20, 2017; Fulda, GERMANY. 2017.
[Oral Communication]
Schrautzer, C;Arzt, L;Bokanovic, D;Laipold, K; Möbs, C;Pfützner, W; Vollmann, J;Reider, N;Bohle, B;Aberer, W;Sturm, G
Can tests distinguish between acute patients, VIT treated patients, and asymptomatically sensitized subjects?.
EAACI (European Academy of Allergy and Clinical Immunology) Congress; JUN, 17-21; Helsinki, FINNLAND. 2017.
[Oral Communication]
Till, H
Anderson Hynes Pyeloplasty: Can we do better Laparoscopically?
16th Congress of Hungarian Association of Pediatric Surgeons with International Participation (HAPS-17); SEPT 14-16,2017; Szeged, HUNGARY. 2017.
[Keynote lecture]
Wiednig, M; Schöffl, C; Aberer, W
Case report on two patients with acquired angioedema treated with Cinryze.
J AM ACAD DERMATOL. 2017; 76(6):AB62-AB62.-Annual Meeting of the American-Academy-of-Dermatology; MAR 03-07, 2017; Orlando, FL.
[Poster]
Web of Science
Wiednig, M; Schöffl, C; Weger, W; Aberer, W
Successful prophylactic treatment of acquired angioedema with plasma derived C1-inhibitor.
ALLERGY. 2017; 72: 720-720.-Congress of the European-Academy-of-Allergy-and-Clinical-Immunology; JUN 17-21, 2017; Helsinki, FINLAND.
[Poster]
Web of Science
Worm, M; Zielen, S; Higenbottam, T; Pfaar, O; Mosges, R; Aberer, W; Kramer, M; Skinner, M; Lees, B
Selection of the optimal dose for an ultra-short course subcutaneous immunotherapy (SCIT) for Rhinoconjunctivitis for Birch Allergic patients
J ALLERGY CLIN IMMUN. 2017; 139(2):AB150-AB150.-Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI); MAR 03-16, 2017; Atlanta, GA.
Doi: 10.1016/j.jaci.2016.12.491
[Oral Communication]
Web of Science
FullText
FullText_MUG
Worm, M; Zielen, S; Higenbottam, T; Pfaar, O; Mosges, R; Aberer, W; Lee, D; Kramer, MF; Skinner, MA
Selection of the optimal dose for an ultra-short course subcutaneous immunotherapy for rhinoconjunctivitis for birch allergic patients. EUDRACT number 2015-000984-15
ALLERGY. 2017; 72: 201-202.-Congress of the European-Academy-of-Allergy-and-Clinical-Immunology; JUN 17-21, 2017; Helsinki, FINLAND.
[Oral Communication]
Web of Science
Aberer, W; Longhurst, H; Bouillet, L; Caballero, T; Fabien, V; Zanichelli, A; Maurer, M; Andresen, I
Characterisation of hereditary angioedema attacks requiring reinjection of icatibant: findings from the icatibant outcome survey
ALLERGY. 2016; 71: 86-86.-Meeting of the European-Academy-of-Allergy-and-Clinical-Immunology; JUN 11-15, 2016; Vienna, AUSTRIA.
[Poster]
Web of Science
Caballero, T; Bouillet, L; Longhurst, HJ; Aberer, W; Maurer, M; Zanichelli, A; Perrin, A; Andresen, I
Gender Analysis of Icatibant-Treatment Outcomes of Acute Angioedema Attacks in Patients with Hereditary Angioedema Type I and II: Results from the Icatibant Outcome Survey
J ALLERGY CLIN IMMUN. 2016; 137(2):AB253-AB253.-Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI); MAR 04-07, 2016; Los Angeles, CA.
Doi: 10.1016/j.jaci.2015.12.910
[Poster]
Web of Science
FullText
FullText_MUG
Longhurst, H; Aberer, W; Bouillet, L; Caballero, T; Bygum, A; Grumach, AS; Fabien, V; Andresen, I; Zanichelli, A; Maurer, M
Hereditary angioedema presents in childhood but is diagnosed in adulthood findings from the Icatibant outcome survey
ALLERGY. 2016; 71: 243-243.-Meeting of the European-Academy-of-Allergy-and-Clinical-Immunology; JUN 11-15, 2016; Vienna, AUSTRIA.
[Oral Communication]
Web of Science
Maurer, M; Caballero, T; Aberer, W; Zanichelli, A; Bouillet, L; Fabien, V; Andresen, I; Longhurst, HJ
The icatibant outcome survey: more than 2900 icatibant-treated attacks in patients with type I or II hereditary angioedema
ALLERGY. 2016; 71: 242-242.-Meeting of the European-Academy-of-Allergy-and-Clinical-Immunology; JUN 11-15, 2016; Vienna, AUSTRIA.
[Oral Communication]
Web of Science
Schrautzer, C; Bokanovic, D; Hemmer, W; Lang, R; Hawranek, T; Schwarz, I; Aberer, W; Sturm, E; Sturm, GJ
Sensitivity and specificity of Hymenoptera allergen components depend on the diagnostic assay employed
11.Wörthersee Symposium; MAY 6, 2016; Klagenfurt, AUSTRIA. 2016.
[Oral Communication]
Zanichelli, A; Magerl, M; Longhurst, HJ; Aberer, W; Caballero, T; Bouillet, L; Bygum, A; Grumach, AS; Fabien, V; Andresen, I; Maurer, M
Improvement in hereditary angioedema diagnosis: findings from the Icatibant Outcome Survey
ALLERGY. 2016; 71: 242-243.-Meeting of the European-Academy-of-Allergy-and-Clinical-Immunology; JUN 11-15, 2016; Vienna, AUSTRIA.
[Poster]
Web of Science
Aberer, E; Aberer, W.
Die besondere Zelle
83. Alpenländischer
Dermatologen
Nachmittag
83. Alpenländischer Dermatologen Nachmittag anläßlich des 75. Geburtstages von em. o.Univ.-Prof. Dr. Dr. h.c. Peter Fritsch
; 14. Oktober 2015; Innsbruck. 2015.
[Oral Communication]
Bokanovic, D; Schwarz, I; Laipold, K; Smolle, C; Schrautzer, C; Wutte, N; Aberer, W; Sturm, GJ
Adherence to venom immunotherapy: when do we lose patients?
European-Academy-of-Allergy-and-Clinical-Immunology Congress; JUN 6-10, 2015; Barcelona, SPAIN. 2015.
[Poster]
Bokanovic, D; Schwarz, I; Laipold, K; Smolle, C; Schrautzer, C; Wutte, N; Aberer, W; Sturm, GJ
Adherence to venom immunotherapy: when do we lose patients?
ALLERGY. 2015; 70: 313-313.-Congress of the European-Academy-of-Allergy-and-Clinical-Immunology; JUN 06-10, 2015; Barcelona, SPAIN.
[Poster]
Web of Science
Caballero, T; Maurer, M; Longhurst, H; Aberer, W; Bouillet, L; Fabien, V; Zanichelli, A
The Icatibant Outcome Survey: Trigger Factors and Premonitory Symptoms of Angioedema Attacks in Patients with Hereditary Angioedema
J ALLERGY CLIN IMMUN. 2015; 135(2):AB278-AB278.-Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI); FEB 20-24, 2015; Houston, TX.
Doi: 10.1016/j.jaci.2014.12.1847
[Oral Communication]
Web of Science
FullText
FullText_MUG
Caballero, T; Zanichelli, A; Aberer, W; Maurer, M; Longhurst, H; Bouillet, L; Fabien, V; Andresen, I
The effect of body mass index on icatibant treatment outcomes in patients with hereditary angioedema with C1 inhibitor deficiency: findings from the Icatibant outcome survey
ALLERGY. 2015; 70: 252-252.-Congress of the European-Academy-of-Allergy-and-Clinical-Immunology; JUN 06-10, 2015; Barcelona, SPAIN.
[Poster]
Web of Science
Laffan, J; Longhurst, H; Zanichelli, A; Caballero, T; Bouillet, L; Aberer, W; Fabien, V; Maurer, M
Evaluation Of Angioedema Due To Acquired C1 Esterase Inhibitor Deficiency; Observational Data From The Icatibant Outcome Survey
CLIN EXP IMMUNOL. .. 2015; 182: 13-13.-UK PIN Meeting; NOV 19-20, 2015; Belfast, NORTH IRELAND.
[Oral Communication]
Web of Science
Longhurst, H; Caballero, T; Aberer, W; Zanichelli, A; Bouillet, L; Maurer, M; Fabien, V; Andresen, I
Long-term outcomes of icatibant in the real-world setting: results from the Icatibant outcome survey
ALLERGY. 2015; 70: 58-58.-Congress of the European-Academy-of-Allergy-and-Clinical-Immunology; JUN 06-10, 2015; Barcelona, SPAIN.
[Poster]
Web of Science
Longhurst, H; Zanichelli, A; Caballero, T; Bouillet, L; Aberer, W; Fabien, V; Maurer, M
The Icatibant Outcome Survey: Observational Data in Patients with Angioedema Due to Acquired C1 Inhibitor (C1-INH) Deficiency
J ALLERGY CLIN IMMUN. 2015; 135(2):AB279-AB279.-Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI); FEB 20-24, 2015; Houston, TX.
Doi: 10.1016/j.jaci.2014.12.1850
[Poster]
Web of Science
FullText
FullText_MUG
Maurer, M; Caballero, T; Aberer, W; Zanichelli, A; Bouillet, L; Fabien, V; Longhurst, H
The Icatibant Outcome Survey: More Than 1500 Icatibant-Treated Attacks in Patients with Type I or II Hereditary Angioedema
J ALLERGY CLIN IMMUN. 2015; 135(2):AB194-AB194.-Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI); FEB 20-24, 2015; Houston, TX.
Doi: 10.1016/j.jaci.2014.12.1568
[Keynote lecture]
Web of Science
FullText
FullText_MUG
Maurer, M; Caballero, T; Aberer, W; Zanichelli, A; Bouillet, L; Fabien, V; Naser, N; Longhurst, H
THE ICATIBANT OUTCOME SURVEY: MORE THAN 2200 ICATIBANT-TREATED ATTACKS IN PATIENTS WITH TYPE I OR II HEREDITARY ANGIOEDEMA
INTERN MED J. 2015; 45: 22-22.
[Poster]
Web of Science
Schrautzer, C; Bokanovic, D; Schwarz, I; Laipold, K; Aberer, W; Sturm, GJ
Sensitivity of sIgE detection to rApi m 1 differs considerably between currently available immunoassays
ALLERGY. 2015; 70: 13-13.-Congress of the European-Academy-of-Allergy-and-Clinical-Immunology; JUN 06-10, 2015; Barcelona, SPAIN.
[Poster]
Web of Science
Schrautzer, C; Bokanovic, D; Schwarz, I; Laipold, K; Aberer, W; Sturm, GJ
Sensitivity of sIgE detection to rApi m 1 differs considerably between currently available immunoassays.
EAACI (European Academy of Allergy and Clinical Immunology) Congress; JUN 6-10, 2015; Barcelona, SPAIN. 2015.
[Oral Communication]
Zanichelli, A; Longhurst, H; Maurer, M; Bouillet, L; Aberer, W; Fabien, V; Caballero, T
History of Misdiagnosis in Patients with Hereditary Angioedema Participating in the Icatibant Outcome Survey
J ALLERGY CLIN IMMUN. 2015; 135(2):AB194-AB194.-Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI); FEB 20-24, 2015; Houston, TX.
Doi: 10.1016/j.jaci.2014.12.1569
[Poster]
Web of Science
FullText
FullText_MUG
Aberer, W; Lumry, W; Bas, M; Bouillet, L; Baptista, J; Riedl, M
Icatibant for laryngeal hereditary angioedema (HAE) attacks: patient/attack characteristics, reinjection rates and symptom outcomes across three open-label extension studies
ALLERGY. 2014; 69: 489-490.-European-Academy-of-Allergy-and-Clinical-Immunology Congress; JUN 07-11, 2014; Copenhagen, DENMARK.
[Poster]
Web of Science
Aberer, W; Maurer, M; Bouillet, L; Perrin, A; Zanichelli, A; Caballero, T; Longhurst, H
The Icatibant Outcome Survey: Characterizing Breakthrough Hereditary Angioedema Attacks In Patients Receiving Long-Term Prophylaxis
J ALLERGY CLIN IMMUN. 2014; 133(2):AB35-AB35.-Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI); FEB 28-MAR 04, 2014; San Diego, CA.
Doi: 10.1016/j.jaci.2013.12.149
[Oral Communication]
Web of Science
FullText
FullText_MUG
Bokanovic, D; Schwarz, I; Kranzelbinder, B; Schuster, C; Laipold, K; Griesbacher, A; Aberer, W; Vollmann, J; Crailsheim, K; Sturm, GJ
Ist die sIgE/sIgG4-Ratio ein möglicher Diskriminator zwischen asymptomatischer und klinisch relevanter Sensibilisierung?
Allergo J Int 2014. 2014; 23(4):144-144.-10. Arbeitsgespräch Insektengiftallergie; JUN 27-28, 2014; Fulda, GERMANY.
[Oral Communication]
Bokanovic, D; Schwarz, I; Schuster, C; Laipold, K; Aberer, W; Sturm, GJ
Asymptomatically sensitised subjects show stronger sIgE/sIgG4 responses after sting challenges compared to subjects with clinically relevant sensitisation after field stings
ALLERGY. 2014; 69: 24-24.-European-Academy-of-Allergy-and-Clinical-Immunology Congress; JUN 07-11, 2014; Copenhagen, DENMARK.
[Oral Communication]
Web of Science
Bokanovic, D; Schwarz, I; Schuster, C; Laipold, K; Aberer, W; Sturm, GJ
Asymptomatically sensitised subjects show stronger sIgE/sIgG4 responses after sting challenges compared to subjects with clinically relevant sensitisation after field stings
European-Academy-of-Allergy-and-Clinical-Immunology Congress; JUN 07-11, 2014; Copenhagen, DENMARK. 2014.
[Poster]
Bretterklieber, A; Beham-Schmid, C; Berghold, A; Strum, GJ; Brezinschek, Ruth; Aberer, W; Aberer, E.
Klonale Mastzellen in unauffälliger Haut bei Anaphylaxie
Programm der Jahrestagung. 2014; -Jahrestagung der ÖGDV 2014; NOV 21-23, 2014; Vienna, AUSTRIA.
[Poster]
Bretterklieber, A; Beham-Schmid,C; Sturm, GJ; Berghold, A;
Brenzinschek, R; Aberer, W; Aberer, E
Anaphylaxie mit klonalen Mastzellen in unauffalliger Haut – eine neue Form der Clonal mast cell disorders (CMD)?
Programm der Jahrestagung. 2014; -Jahrestagung der ÖGDV 2014; NOV 21-23, 2014; Vienna, AUSTRIA.
[Oral Communication]
Caballero, T; Aberer, W; Longhurst, H; Maurer, M; Zanichelli, A; Fabien, V; Bouillet, L
The Icatibant Outcome Survey: experience of hereditary angioedema management from four European countries
ALLERGY. 2014; 69: 54-54.-European-Academy-of-Allergy-and-Clinical-Immunology Congress; JUN 07-11, 2014; Copenhagen, DENMARK.
[Oral Communication]
Web of Science
Caballero, T; Caminoa, MJ; Perez-Fernandez, E; Gomez-Traseira, C; Aabom, A; Aberer, W; Betschel, SD; Bygum, A; Csuka, D; Farkas, H; Gomide, M; Groffik, A; Grumach, AS; Leivobich, I; Malbran, A; Mihaly, E; Moldovan, D; Obtulowicz, K; Porebski, G; Rayonne, C; Reshef, A; Staubach, P; Wiednig, M; Forjaz, MJ; Prior, N
Health-Related Quality Of Life (HRQoL) In Adult Patients With Hereditary Angioedema Due To C1 Inhibitor Deficiency (HAE-C1-INH) Assessed By SF-36v2
J ALLERGY CLIN IMMUN. 2014; 133(2):AB34-AB34.-Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI); FEB 28-MAR 04, 2014; San Diego, CA.
Doi: 10.1016/j.jaci.2013.12.147
[Poster]
Web of Science
FullText
FullText_MUG
de Rojas, DHF; Ibanez, E; Longhurst, H; Maurer, M; Fabien, V; Aberer, W; Bouillet, L; Zanichelli, A; Caballero, T
The Icatibant Outcome Survey: Rate and Impact Of Treatment By Self-Administration
J ALLERGY CLIN IMMUN. 2014; 133(2):AB35-AB35.-Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI); FEB 28-MAR 04, 2014; San Diego, CA.
[Poster]
Web of Science
Grims, RH; Kränke, B; Aberer, W
Urtikaria nach Zahnarztbesuch.
Dermatologie in Beruf und Umwelt. 2014; 62(2):57-57.-11. Dermatologisches Alpenseminar; JUN 11-14, 2014; Grainau, GERMANY.
[Oral Communication]
Inzinger, M; Weger, W; Wippel-Slupetzky, K; Fleischanderl, B; Richter, L; Mlynek, A; Viznerova, P; Scheurecker, C; Sandor, N; Haring, N; Sator, P; Tatarski, R; Tanew, A; Painsi, C; Mairhofer, D; Moser-Oberthaler, S; Ponholzer, P; Brenner, W; Salmhofer, W; Stingl, G; Saxinger, W; Rappersberger, K; Klein, G; Riedl, E; Aubock, J; Kolli, C; Strohal, R; Steiner, A; Selhofer, S; Pehamberger, H; Lange-Asschenfeldt, B; Trautinger, F; Reider, N; Vloc-Platzer, B; Legat, FJ; Mullegger, R; Hintner, H; Ratzinger, G; Schmuth, M; Hofer, A; Gruber-Wackernagel, A; Aberer, W; Quehenberger, F; Wolf, P
Drug adherence to ustekinumab in the treatment of plaque psoriasis under daily life conditions: report from the Psoriasis Registry Austria
BRIT J DERMATOL. . 2014; 171(6):E168-E168.-7th International Congress of Psoriasis - From Gene to Clinic; DEC 11-13, 2014; London, ENGLAND.
[Poster]
Web of Science
Inzinger,M,; Weger,W; Wippel-Slupetzky,K;
Fleischanderl, B; Richter,L; Mlynek, A;
Viznerova, P; Scheurecker,C; Sandor, N;
Häring,N; SatorP; Tatarski, R; Tanew, A; Painsi,C; Mairhofer,D; Moser-Oberthaler,S;
Ponholzer, P; Brenner,W; Salmhofer,W;
Stingl,G; Saxinger,W; Rappersberger,K;
Klein,G; Riedl, E; J. Auböck, J; Kölli,C; Strohal,R;
Steiner,A; Selhofer,S; Pehamberger, H;
Lange-Asschenfeldt, B; TrautingerF; Reider, N;
Vloc-Platzer, B; Legat FJ; Müllegger, R;
Hintner, H; Ratzinger, G; Schmuth, M; Hofer, A;
Gruber-Wackernagel,A; Aberer, W;
Quehenberger, F; Wolf, P
7th International Congress of psoriasis: from gene to Clinic
Brit J Dermatol . 2014; 171(12):e168-e168.-Drug adherence to ustekinumab in the treatment of
plaque psoriasis under daily life conditions: report
from the Psoriasis Registry Austria; DEC 11th-13th, 2014; London, UK . (ISBN: 1365-2133 )
[Poster]
Inzinger,M,; Weger,W; Wippel-Slupetzky,K; Fleischanderl, B; Richter,L; Mlynek, A; Viznerova, P; Scheurecker,C; Sandor, N; Häring,N; SatorP; Tatarski, R; Tanew, A; Painsi,C; Mairhofer,D; Moser-Oberthaler,S; Ponholzer, P; Brenner,W; Salmhofer,W; Stingl,G; Saxinger,W; Rappersberger,K; Klein,G; Riedl, E; J. Auböck, J; Kölli,C; Strohal,R; Steiner,A; Selhofer,S; Pehamberger, H; Lange-Asschenfeldt, B; TrautingerF; Reider, N; Vloc-Platzer, B; Legat FJ; Müllegger, R; Hintner, H; Ratzinger, G; Schmuth, M; Hofer, A; Gruber-Wackernagel,A; Aberer, W; Quehenberger, F; Wolf, P
Drug adherence to ustekinumab in the treatment of plaque psoriasis under daily life conditions: Report from Posriasis Registry Austria.
Photodermatologie Tage 2014 Graz; OCT 23rd, 2014; Graz, AUSTRIA. 2014.
[Poster]
Inzinger,M,; Wippel-Slupetzky,K; Weger,W; Fleischanderl, B; Richter,L; Mlynek, A; Viznerova, P; Scheurecker,C; Sandor, N; Häring,N; SatorP; Tatarski, R; Tanew, A; Painsi,C; Mairhofer,D; Moser-Oberthaler,S; Ponholzer, P; Brenner,W; Salmhofer,W; Stingl,G; Saxinger,W; Rappersberger,K; Klein,G; Riedl, E; J. Auböck, J; Kölli,C; Strohal,R; Steiner,A; Selhofer,S; Pehamberger, H; Lange-Asschenfeldt, B; TrautingerF; Reider, N; Vloc-Platzer, B; Legat FJ; Müllegger, R; Hintner, H; Ratzinger, G; Schmuth, M; Hofer, A; Gruber-Wackernagel,A; Aberer, W; Quehenberger, F; Wolf, P
Drug adherence of tumor-necrosis factor-alpha Inhibitors in the Treatment of plaque psoriasis under daily life conditions in Austria
Photodermatologie Tage 2014 Graz ; OCt 23rd, 2014; Graz, Austria . 2014.
[Poster]
Inzinger,M,; Wippel-Slupetzky,K; Weger,W; Fleischanderl, B; Richter,L; Mlynek, A; Viznerova, P; Scheurecker,C; Sandor, N; Häring,N; SatorP; Tatarski, R; Tanew, A; Painsi,C; Mairhofer,D; Moser-Oberthaler,S; Ponholzer, P; Brenner,W; Salmhofer,W; Stingl,G; Saxinger,W; Rappersberger,K; Klein,G; Riedl, E; J. Auböck, J; Kölli,C; Strohal,R; Steiner,A; Selhofer,S; Pehamberger, H; Lange-Asschenfeldt, B; TrautingerF; Reider, N; Vloc-Platzer, B; Legat FJ; Müllegger, R; Hintner, H; Ratzinger, G; Schmuth, M; Hofer, A; Gruber-Wackernagel,A; Aberer, W; Quehenberger, F; Wolf, P
Intermediate to Long-term efficacy of tumor-necrosis factor (TNF)- alpha inhibitors in the treatmet of Plaque Psoriasis under daily life conditions in Austria
Photodermatologie Tage 2014 Graz ; OCT 23rd, 2014 ; Graz, AUSTRIA. 2014.
[Poster]
Longhurst, H; Aberer, W; Bouillet, L; Caballero, T; Maurer, M; Fabien, V; Zanichelli, A
The Icatibant Outcome Survey: treatment of laryngeal hereditary angioedema attacks
ALLERGY. 2014; 69: 53-54.-European-Academy-of-Allergy-and-Clinical-Immunology Congress; JUN 07-11, 2014; Copenhagen, DENMARK.
[Poster]
Web of Science
Longhurst, H; Maurer, M; Fabien, V; Aberer, W; Bouillet, L; Zanichelli, A; Caballero, T
The Icatibant Outcome Survey: Characteristics Of Patients With Hereditary Angioedema Requiring Reinjection
J ALLERGY CLIN IMMUN. 2014; 133(2):AB34-AB34.-Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI); FEB 28-MAR 04, 2014; San Diego, CA.
Doi: 10.1016/j.jaci.2013.12.148
[Poster]
Web of Science
FullText
FullText_MUG
Prior, N; Remor, E; Perez-Fernandez, E; Gomez-Traseira, C; Caminoa, MJ; Gaya, F; Aberer, W; Barrera, OM; Betschel, SD; Bouillet, L; Bygum, A; Farkas, H; Grumach, AS; Grivcheva-Panovska, V; Levi, M; Longhurst, H; Malbran, A; Moldovan, D; Porebski, G; Reshef, A; Staubach, P; Zanichelli, A; Zhi, YX; Caballero, T
IHAE-Qol: Specific Health-Related Quality Of Life (HRQoL) Questionnaire In Hereditary Angioedema Due To C1 Inhibitor Deficiency (HAE-C1INH)
J ALLERGY CLIN IMMUN. 2014; 133(2):AB33-AB33.-Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI); FEB 28-MAR 04, 2014; San Diego, CA.
Doi: 10.1016/j.jaci.2013.12.145
[Poster]
Web of Science
FullText
FullText_MUG
PsoRA Study Group:
Inzinger, M; Weger, W; Wippel-Slupetzky,K; Painsi, P; Richter, L; Mlynek, A; Fleischanderl, B; Scheurecker, C; Sandor, N; Sator, P;
Viznerova, P; Mairhofer,D; Moser-Oberthaler, S, Tanew, A; Häring, N;
Tatarski, R; Ponholzer, P; Brenner, W; Salmhofer, W; Stingl, G;
Patscheider, M; Rappersberger,K; Klein, G; Saxinger, W; Auböck, J;
Kölli, C; Steiner, A; Riedl E, Trautinger, F; Ratzinger, G; Pehamberger, H; Strohal, R; Selhofer, S; Volc-Platzer, B; Legat, F;
Lange-Asschenfeldt, B; Müllegger, R; Reider, R; Hintner, H; Schmuth, M;
Hofer, A; Gruber-Wackernagl, A; Aberer,W; Quehenberger, F;
Wolf, P
Department of
Reported comorbitities in patients with psoriasis who are enrolled in the Psoriasis
Registry Austria (PsoRA)
ÖGDV Jahrestagung Abstractband . 2014; 25-25.-Jahrestagung der ÖGDV ; NOV 21-23, 2014; Vienna, Austria .
[Oral Communication]
Schwarz, I; Bokanovic, D; Aberer, W; Sturm, G;
Is the highest value of sIgE an indicator for the causative insect?.
EAACI Congress; JUN 07-11, 2014; Copenhagen, DENMARK. 2014.
[Poster]
Schwarz, I; Bokanovic, D; Aberer, W; Sturm, GJ
Is the highest value of sIgE an indicator for the causative insect?
ALLERGY. 2014; 69: 114-115.-European-Academy-of-Allergy-and-Clinical-Immunology Congress; JUN 07-11, 2014; Copenhagen, DENMARK.
[Poster]
Web of Science
Schwarz,I; Grims, RH; Aberer, W; Komericki, P;
Intraoperative anaphylaktische Reaktion Grad IV
ÖGDV; NOV 21-23, 2014; Vienna, AUSTRIA. 2014.
[Oral Communication]
Weger, W; Inzinger, M, Wippel Slupetzky, K, Wolf, P for PsoRA
PsoRA Study Group: Fleischanderl B, Richter L, Mlynek A, Viznerova P, Scheurecker C,
Sandor N, Häring N, Sator P, Tatarski R, Tanew A, Painsi C, Mairhofer D, Moser-Oberhtaler S,
Ponholzer P, Brenner W, Salmhofer W, Stingl G, Saxinger W, Rappersberger K, Klein G, Riedl
E, Auböck J, Kölli C, Strohal R, Steiner A, Selhofer S, Pehamberger H, Lange-Asschenfeldt B,
Trautinger F, Reider N, Volc-Platzer B, Legat FJ, Müllegger R, Hintner H, Ratzinger G,
Schmuth M, Hofer A, Gruber-Wackernagel A, Aberer W, Quehenberger F
Drug survival of ustekinumab in the treatment of psoriasis under daily life condidions: report from Psoriasis Registry Austria
ÖGDV Jahrestagung 2014 . 2014; 39-39.-Jahrestagung 2014 der ÖGDV ; NOV 21-23, 2014; Vienna, Austria .
[Oral Communication]
Wolf, H; Pfaar, O; de Rojas, DHF; Aberer, W; Kleine-Tebbe, J; Walmar, M; Nedergaard, P; Wustenberg, E
Aluminium did not accumulate in patients with allergic rhinoconjunctivitis during a 1-year treatment with an immunologically enhanced subcutaneous allergy immunotherapy preparation in a randomised, double-blinded, placebo-controlled multinational trial
ALLERGY. 2014; 69: 183-184.-European-Academy-of-Allergy-and-Clinical-Immunology Congress; JUN 07-11, 2014; Copenhagen, DENMARK.
[Oral Communication]
Web of Science
Aberer, W; Bygum, A; Nair, N; Kivity, S;
Safety and Convenience of Self-Administered Icatibant for the Treatment of Acute Hereditary Angioedema Attacks.
J ALLERG CLIN IMMUNOL. 2013; 131(2):AB32-AB32.-Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI); FEB 22-26, 2013; San Antonio, TX.
Doi: 10.1016/j.jaci.2012.12.797
[Poster]
Web of Science
FullText
FullText_MUG
Aberer, W; Lumry, W; Farkas, H; Bernstein, JA; Bouillet, L; Baptista, J; Reidl, M
Evaluation of icatibant for the repeated treatment of hereditary angioedema attacks across three phase III open label extension studies
ALLERGY. 2013; 68: 16-16.-World Allergy and Asthma Congress of the European-Academy-of-Allergy-and-Clinical-Immunology and World-Allergy-Organization; JUN 22-26, 2013; Milan, ITALY.
[Poster]
Web of Science
Bokanovic, D; Kranzelbinder, B; Schuster, C; Sturm, EM; Vollmann, J; Crailsheim, K; Hemmer, W; Aberer, W; Sturm, GJ
Sensitization to hymenoptera venoms is common but rarely associated with systemic symptoms.
Jahrestagung der ÖGDV; NOV 22-24, 2013; Vienna, AUSTRIA. 2013.
[Poster]
Bokanovic, D; Laipold, K; Pickl-Herk, B; Griesbacher, A; Aberer, W; Vollmann, J; Crailsheim, K; Sturm, GJ
Negative predictive value of the basophil activation test in hymenoptera venom allergy
ALLERGY. 2013; 68: 491-491.-World Allergy and Asthma Congress of the European-Academy-of-Allergy-and-Clinical-Immunology and World-Allergy-Organization; JUN 22-26, 2013; Milan, ITALY.
[Poster]
Web of Science
Caminoa, M; Caballero, T; Perez-Fernandez, E; Gomez-Traseira, C; Gaya, F; Aabom, A; Aberer, W; Betschel, S; Bygum, A; Csuka, D; Farkas, H; Groffik, A; Gomide, M; Grumach, A; Leibovich, I; Malbran, A; Mihaly, E; Moldovan, D; Obtulowicz, K; Porebski, G; Rayonne, C; Reshef, A; Staubach, P; Wiednig, M; Prior, N
Hereditary angioedema due to C1 inhibitor deficiency: clinical descriptive study in an international cohort
ALLERGY. 2013; 68: 61-61.-World Allergy and Asthma Congress of the European-Academy-of-Allergy-and-Clinical-Immunology and World-Allergy-Organization; JUN 22-26, 2013; Milan, ITALY.
[Poster]
Web of Science
Fruhwald, S
Case: Before I start
ESICM Lives, 26th Annual Congress; OKT 5-9, 2013; Paris. 2013.
[Oral Communication]
Komericki, P; Kranzelbinder, B; Wiednig, M; Aberer W
Therapieversagen von oral verabreichtem Cefixim bei genitalen Infektionen mit Cefixim-empfindlichen N. gonorrhoeae
Jahrestagung der OEGDV; NOV 22-24, 2013; Vienna, Austria. 2013.
[Poster]
Kranzelbinder, B; Wiednig, M; Aberer, W; Komericki, P
Cefixime treatment failure in infections with
cefixime susceptible N. gonorrhoea strains
Journal of Sexually Transmitted Infections. 2013; 89(1):-International Union against sexually transmitted infections; JUL 14-17, 2013; Vienna, AUSTRIA.
[Poster]
Longhurst, H; Aberer, W; Bouillet, L; Caballero, T; Fabien, V; Kanny, G; Zanichelli, A; Maurer, M;
Benefits of Early Administration with Icatibant for the Treatment of Hereditary Angioedema Attacks.
J ALLERG CLIN IMMUNOL. 2013; 131(2):AB33-AB33.-Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI); FEB 22-26, 2013; San Antonio, TX.
Doi: 10.1016/j.jaci.2012.12.798
[Poster]
Web of Science
FullText
FullText_MUG
Longhurst, H; Aberer, W; Bouillet, L; Caballero, T; Fabien, V; Zanichelli, A; Maurer, M
Early treatment with icatibant significantly reduces duration and time to resolution of hereditary angioedema attacks
ALLERGY. 2013; 68: 62-62.-World Allergy and Asthma Congress of the European-Academy-of-Allergy-and-Clinical-Immunology and World-Allergy-Organization; JUN 22-26, 2013; Milan, ITALY.
[Poster]
Web of Science
Longhurst, H; Aberer, W; Bouillet, L; Caballero, T; Fabien, V; Zanichelli, A; Maurer, M
Analysis of characteristics associated with reinjection of icatibant: results from the Icatibant Outcome Survey
ALLERGY. 2013; 68: 430-430.-World Allergy and Asthma Congress of the European-Academy-of-Allergy-and-Clinical-Immunology and World-Allergy-Organization; JUN 22-26, 2013; Milan, ITALY.
[Poster]
Web of Science
Prior, N; Caminoa, M; Perez-Fernandez, E; Gomez-Traseira, C; Gaya, F; Aabom, A; Aberer, W; Betschel, S; Bygum, A; Csuka, D; Farkas, H; Groffik, A; Gomide, M; Grumach, AS; Leibovich, I; Malbran, A; Mihaly, E; Moldovan, D; Obtulowicz, K; Porebski, G; Chavannes, CR; Reshef, A; Staubach, P; Wiednig, M; Caballero, T
Hereditary angioedema: clinical differences among countries
ALLERGY. 2013; 68: 611-612.-World Allergy and Asthma Congress of the European-Academy-of-Allergy-and-Clinical-Immunology and World-Allergy-Organization; JUN 22-26, 2013; Milan, ITALY.
[Poster]
Web of Science
Prior, N; Remor, E; Perez-Fernandez, E; Gomez-Traseira, C; Caminoa, M; Gaya, F; Aabom, A; Aberer, W; Betschel, S; Bygum, A; Csuka, D; Farkas, H; Groffik, A; Gomide, M; Grumach, A; Leibovich, I; Malbran, A; Mihaly, E; Moldovan, D; Obtulowicz, K; Porebski, G; Rayonne, C; Reshef, A; Staubach, P; Wiednig, M; Caballero, T
Validation of the international quality of life questionnaire for hereditary angioedema
ALLERGY. 2013; 68: 111-111.-World Allergy and Asthma Congress of the European-Academy-of-Allergy-and-Clinical-Immunology and World-Allergy-Organization; JUN 22-26, 2013; Milan, ITALY.
[Poster]
Web of Science
Schröder, W; Wiednig, M; Reiter, H; Aberer, W; Bretterklieber, A; Kroisel, PM; Felbor, U
Familial cerebral cavernous malformations with cutaneous
manifestations caused by a novel CCM3 mutation
http://www.gfhev.de/kongress_archiv/2013%20de/kongress/GfH-Tagung_Abstractband_2013.pdf. 2013; -24. Jahrestagung der Deutschen Gesellschaft für Humangenetik
gemeinsam mit der Österreichischen Gesellschaft für Humangenetik
und der Schweizerischen Gesellschaft für Medizinische Genetik; MAR 20-22, 2013; Dresden, GERMANY.
[Poster]
FullText
Schuster, C; Kranzelbinder, B; Sturm, G; Aberer, W; Komericki, P
Acute tongue ulcer
ALLERGY. 2013; 68: 527-527.-World Allergy and Asthma Congress of the European-Academy-of-Allergy-and-Clinical-Immunology and World-Allergy-Organization; JUN 22-26, 2013; Milan, ITALY.
[Poster]
Web of Science
Schwarz, I; Massone, C; Horn, M; Bokanovic, D; Schuster, C; Laipold, K; Aberer, W; Sturm, GJ
Does the sting localisation play a role for the severity of symptoms in hymenoptera venom allergy?
ALLERGY. 2013; 68: 631-631.-World Allergy and Asthma Congress of the European-Academy-of-Allergy-and-Clinical-Immunology and World-Allergy-Organization; JUN 22-26, 2013; Milan, ITALY.
[Poster]
Web of Science
Bas, M; Ritchie, B; Lumry, W; Aberer, W;
A pooled analysis of three phase III trials to explore the efficacy of icatibant in the treatment of laryngeal attacks of type I and II hereditary angioedema.
ALLERGY. 2012; 67: 197-198.-31st Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI); JUN 16-20, 2012; Geneva, SWITZERLAND.
[Oral Communication]
Web of Science
Bokanovic, D; Leonhartsberger, T; Griesbacher, A; Aberer, W; Sturm, G;
Is the emergency kit in its present form really able to save any life?.
ALLERGY. ALLERGY67: 227-227. HOBOKEN: WILEY-BLACKWELL; ( Presented at: 31st Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Geneva, SWITZERLAND, JUN 16-20, 2012)
[Poster]
Web of Science
Bokanovic, D; Leonhartsberger, T; Griesbacher, A; Aberer, W; Sturm, GJ
Kann das Notfallset in dieser Form Leben retten?
ÖGDV Jahrestagung 2012; NOV 30 - DEC 2, 2012; Linz, AUSTRIA. 2012.
[Poster]
Glatz, M; Degen, D; Aberer, W; French, LE; Muellegger, RR
Erysipelas at uncommon sites
J INVEST DERMATOL. 2012; 132: S53-S53.-75th Annual Meeting of the Society-for-Investigative-Dermatology; MAY 09-12, 2012; Raleigh, NC.
[Poster]
Web of Science
Kranzelbinder, B; Aberer, W; Weger, W
Bullous lichen planus - a rare variant of lichen planus.
Abstracts on CD ROM
21st EADV Congress. 2012; -21st EADV Congress; SEP 27-30, 2012 ; Prague, CZECH REPUBLIC . (ISBN: 978-88-906829-2-6 )
[Poster]
Schuster, C; Aberer, W; Kränke B
Orale Candidose: Relevanz für die Epikutantestung mit Zahnprothesenmaterialien
Dermatologie in Beruf und Umwelt. 2012; 60(1):29-30.-10. Dermatologisches Alpenseminar; May 17-19, 2012; Berchtesgaden, GERMANY.
[Oral Communication]
Wiednig, M; Reiter, H; Weger, W; Kroisel, P; Kranzelbinder, B; Felbor, U; Schroeder, W; Aberer W; Bretterklieber, A
Kutane Manifestationen bei zerebraler kavernöser Malformation mit Erstbeschreibung einer neuen Mutation im CCM3 Gen.
ÖGDV 2012- Abstractband . 2012; 61-62.-Jahrestagung 2012 der ÖGDV ; NOV 30-DEC 2, 2012; Linz, AUSTRIA.
[Poster]
Wutte, N; Palfner, M; Auer, H; Ruckenbauer, G; Valentin, T; Seeber, K; Aberer, W; Krause, R; Hönigl, M
Toxocariasis and DRESS Syndrome in an oncological patient
Jahrestagung der ÖGTP; NOV 23-24; Innsbuck, AUSTRIA. 2012.
[Poster]
Bokanovic, D; Grims, R; Laipold, K; Aberer, W; Sturm, GJ
Soforttyp-Allergie auf LMW-Heparin
16. Grazer Allergietag im Rahmen der ÖGAI-Jahrestagung; SEP 17, 2011; Graz, AUSTRIA. 2011.
[Oral Communication]
Bokanovic, D; Laipold, K; Aberer, W; Sturm, GJ
Der Basophilenaktivierungstest (BAT) verglichen mit neuen und etablierten diagnostischen Methoden im Bereich der Gräserpollenallergie
Jahrestagung 2011 der Österreichischen Gesellschaft für Dermatologie und Venerologie; NOV 11-13, 2011; Linz, AUSTRIA. 2011.
[Poster]
Bokanovic, D; Laipold, K; Griesbacher, A; Aberer, W;
Vollmann, J; Crailshaim, K; Schuster, C; Sturm, GJ
Alterations of sIgE and sIgG4 levels after bee and wasp stings differ between asymptomatically sensitized subjects and venom allergic patients with and without immunotherapy.
EAACI Congress 2011; JUN 11-15, 2011; Istanbul, TURKEY. 2011.
[Poster]
Bokanovic, D; Laipold, K; Griesbacher, A; Aberer, W;
Vollmann, J; Crailshaim, K; Schuster,C; Sturm, GJ
Alterations of sIgE and sIgG4 levels after bee and wasp stings differ between asymptomatically sensitized subjects and venom allergic patients with and without immunotherapy
EAACI Congress 2011; JUN 11-15, 2011; Istanbul, TURKEY. 2011.
[Oral Communication]
Bokanovic, D; Laipold, K; Griesbacher, A; Aberer, W; Vollmann, J; Crailsheim, K; Schuster, C; Sturm, GJ
Unterschiedliche sIgE- und sIgG4-Verläufe nach Bienen- und Wespenstichen von asymptomatisch Sensibilisierten und Insektengiftallergikern mit und ohne Immuntherapie.
Allergo J. 2011; 20(4):195-196.-9. Arbeitsgespräch Insektengiftallergie; MAY 20-21, 2011; Landshut, GERMANY.
[Oral Communication]
Glatz, M; Degen, D; Aberer, W; French, L; Mullegger, R
Academic Reading, Clinical Studies and Diagnosis
J DTSCH DERMATOL GES. 2011; 9: 135-135.
[Oral Communication]
Web of Science
Grims, RH; Schuster, Ch; Prüller, F; Rosskopf, K; Massone, C; Aberer, W
Gardner Diamond Syndrom Klinische Abklärung eines Mythos (?)
ÖGDV Jahrestagung 2011, Kurzfassungen der Lehrreichen Fälle. 2011; 19-20.-Jahrestagung der ÖGDV 2011; NOV 11-13, 2011; Linz, Austria.
[Oral Communication]
Komericki, P; Akkilic-Materna, M; Strimitzer, T; Aberer, W
Efficacy and Safety of Imiquimod Versus Podophyllotoxin in the Treatment of Anogenital Warts
J DTSCH DERMATOL GES. 2011; 9: 154-155.
[Poster]
Web of Science
Schuster, C; Aberer W; Kränke B
Laugenverätzung der Hände mit N-Methyl-2-pyrrolidon-Lösungsmittel
Dermatologie in Beruf und Umwelt. 2011; 59(3):137-137.-11. Tagung der Arbeitsgemeinschaft für Berufs- und Umweltdermatologie; OCT 27-29, 2011; Dresden.
[Poster]
Schuster C; Kränke, B; Aberer W; Sturm, G; Komericki, P
Fixed drug eruption on the penis due to oxcarbazepine
p 63. 2011; -30th congress of the European Academy of Allergy and Clinical Immunology; JUN 11-15; Istanbul, Turkey.
[Poster]
Schuster, C; Mofarrah, R; Aberer, W; Kränke, B
Fallstricke bei der Epikutantestung von Zahnprothesenmaterialien
P 49. 2011; 113-113.-Jahrestagung der Österreichischen Gesellschaft für Dermatologie und Venerologie; NOV 11-13, 2011; Linz.
[Poster]
Sturm, GJ; Kranzelbinder, B; Schuster, C; Bokanovic, D; Sturm, E; Vollmann, J; Griesbacher, A; Crailsheim, K; Aberer, W
Stichprovokationen bei asymptomatisch Sensibilisierten: Erhöhtes Risiko für gesteigerte Lokalreaktionen, jedoch nicht für systemische Stichreaktionen
Allergo J 2011; 20:195.2011; -9. Arbeitsgespräch Insektengiftallergie; MAY 20-21, 2011; Landshut, GERMANY. (ISBN: 0941-8849 )
[Oral Communication]
Varga, EM;Kausar, F;Sturm,G;Aberer, W;Zach, M;Durham,SR;Shamji,M
Repeated exposure to bee venom during the beekeeping season induces high levels of venom-specific IgG4 serum antibodies with serum inhibitory activity for IgE-facilitated antigen binding in non-allergic beekeepers
Allergy. 2011; 66(94):1-104.-Annual Congress of EAACI, European Academy of Allergy and Clinical Immunology; June 11-15, 2011; Istanbul.
[Oral Communication]
Wiednig, M; Aberer, W; Weger; W; Kranzelbinder, B, Kränke, B
Allopurinol induced DRESS syndrome.
JEADV; Abstracts on CD Roms . 2011; 164-164.-20th Congress of the European Academy of Dermatology and Venerology; OCT 20-24; 2011; Lisbon, Portugal . (ISBN: 978-989-20-2609-1 )
[Poster]
Wutte, N; Aberer, W; Berghold, A; Reiter, H; Aberer, E
CXCL13 und BAFF: Neue Biomarker bei Systemischer Sklerodermie
Jahrestagung der Österreichischen Gesellschaft für Dermatologie und Venerologie; 11.-13.11.2011; Linz / Österreich. 2011.
[Oral Communication]
Wutte, N; Aberer,W; Berghold, A; Reiter, H; Aberer,E
CXCL13 und BAFF als neue Biomarker bei Systemischer Sklerodermie
Programm: ÖGDV Jahrestagung 2011. 2011; -ÖGDV Jahrestagung; NOV 11-13, 2011; Linz, AUSTRIA.
[Oral Communication]
Aberer, W
Komponenten-basierte Diagnostik, Schwerpunkt Insektengiftallergie
15. Grazer Allergietag; SEP 25, 2010; Graz. 2010.
[Keynote lecture]
Aberer, W
Behandlung des chronischen Handekzems; neueste Erkenntnisse
Almirall Fortbildungssymposium; DEC 3, 2010; Bregenz, AUSTRIA. 2010.
[Keynote lecture]
Aberer, W
Therapie des hereditären Angioödems
Österreichische Gesellschaft für Dermatologie und Venerologie; NOV 19-21, 2010; Vienna, AUSTRIA. 2010.
[Oral Communication]
Aberer, W
Wirkt Hautschutz? Ergebnisse der österreichischen Haut- und Präventionsstudie
Gesunde Haut-Informationsveranstaltung der AUVA; OCT 19, 2010; Vienna, AUSTRIA. 2010.
[Oral Communication]
Aberer, W
Angioödeme: Klassifikation, Diagnose, Therapie.
Dermakademie der Wissenschaftlichen Gesellschaft der Steirischen Dermatologen; OCT 15-16, 2010; Graz, AUSTRIA. 2010.
[Oral Communication]
Aberer, W
Mastocytosis and anaphylaxis
19th Congress of the European Academy of Dermatology and Venerology; OCT 6-10, 2010; Göteborg, SWEDEN. 2010.
[Oral Communication]
Aberer, W
Die Hautbarriere und ihre Defekte: wenn die Mauer bröckelt!
48. Jahrestagung Österreichische Gesellschaft für Kinder- und Jugendheilkunde; SEP 30 - OCT 2, 2010; Linz. 2010.
[Oral Communication]
Aberer, W
HAE-treatment in Austria: Challenges and opportunities
Firazyr Advisory Board meeting; MAR 3, 2010; London, UK. 2010.
[Keynote lecture]
Aberer, W
Das hereditäre Angioödem und seine Differentialdiagnosen
Fortbildungsveranstaltung für HNO-Ärzte; MAI 6, 2010; St. Michael. 2010.
[Keynote lecture]
Aberer, W
Das hereditäre Angioödem und seine Differentialdiagnosen
Fortbildungsserie SMZ-Ost; MAI 27, 2010; Wien. 2010.
[Keynote lecture]
Aberer, W
Skin testing for IgE-mediated drug allergy
European Society for Contact Dermatitis; SEP 15-18, 2010; Strassburg, FRANKREICH. 2010.
[Keynote lecture]
Aberer, W
Differentialdiagnosen: Fälle aus der Praxis für die Praxis
Dermatology Summit; MAR 19-20, 2010; Wien. 2010.
[Keynote lecture]
Aberer, W
Klinik, Histopathologie, Laborbefunde - klinisch-pathologische Konferenz
Fortbildungstagung der Österreichischen Akademie für Dermatologische Fortbildung; JUN 2-5, 2010; Bad Ischl. 2010.
[Keynote lecture]
Aberer, W
ISAC: von der Forschung in die Praxis
Expertentreffen zum Thema ISAC; MAR 30, 2010; Wien. 2010.
[Keynote lecture]
Aberer, W
Das hereditäre Angioödem
Fortbildungsserie des KH Rudolfstiftung; MAI 31, 2010; Wien. 2010.
[Keynote lecture]
Aberer, W
Insektengiftimmuntherapie - State of the art
Expertenmeeting Diagnose und Therapie der Insektengiftallergien; MAI 26, 2010; Wien. 2010.
[Keynote lecture]
Aberer, W
Allergische Erkrankungen
2. Update Dermatologie; JAN 22-24, 2010; Pichlarn. 2010.
[Keynote lecture]
Aberer, W
Skin manifestations in drug allergy: clincal picture
Skin Allergy Meeting of the EAACI; NOV 11-13, 2010; Venice, ITALIA. 2010.
[Oral Communication]
Aberer, W
Das HAE und seine Differentialdiagnosen
Fortbildungsveranstaltung der Derma-Abteilung KH Wilhelminenspital; DEC 15, 2010; Vienna, AUSTRIA. 2010.
[Keynote lecture]
Aberer, W
Chronisches Handekzem Diagnose und Therapie
Satellitensymposium der Firma Almirall anlässlich der ÖGDV Jahrestagung; NOV 19-21, 2010; Vienna, AUSTRIA. 2010.
[Keynote lecture]
Aberer, W
Hautschutz am Arbeitsplatz. Österreichische Situation aus der Sicht eines Arztes
Workshop Hautschutz am Arbeitsplatz der AUVA; NOV 18, 2010; Vienna, AUSTRIA. 2010.
[Oral Communication]
Aberer, W
Leitlinien, die man kennen muss
New trends in der Allergologie/Bodenseesymposium; NOV 12-13, 2010; Bregenz, AUSTRIA. 2010.
[Oral Communication]
Aberer, W
Introduction und Summary / Case studies forum
HAE autumn symposium; OCT 22-23, 2010; Prague, TSCHECH REPUBLIC. 2010.
[Oral Communication]
Aberer, W
Aus der berufsdermatologischen Praxis
Gesunde Haut-Informationsveranstaltung der AUVA; OCT 19, 2010; Vienna, AUSTRIA. 2010.
[Oral Communication]
Aberer, W
Skin testing for drug allergy.
19th Congress of the European Academy of Dermatology and Venerology; OCT 6-10, 2010; Göteborg, SWEDEN. 2010.
[Oral Communication]
Aberer, W
Kontaktallergene im heimischen Garten
Fortbildungsveranstaltung der Uni Freiburg; JUN 26, 2010; Freiburg, DEUTSCHLAND. 2010.
[Keynote lecture]
Aberer, W
A novel approach to the acute treatment of hereditary angioedema.
Brasilian Launch Event of Firazyr; Apr 30 - MAI 1, 2010; Sao Paulo, BRASILIEN. 2010.
[Keynote lecture]
Aberer, W
Drug provocation tests
4th Int Drug hypersensitivity meeting; APR 22-24, 2010; Rom, ITALIEN. 2010.
[Keynote lecture]
Aberer, W
Herpeserkrankungen
Fortbildungsveranstaltung für die Steiermärkischen Apotheker; JUN 30, 2010; Graz. 2010.
[Keynote lecture]
Aberer, W
Stichprovokation bei latenter Insektengiftsensibilisierung
8. Wörthersee- Symposium What´s new in Allergy; JUN 18-20, 2010; Velden. 2010.
[Keynote lecture]
Aberer, W
Das hereditäre Angioödem und seine Differentialdiagnosen
3. HNO-Wörthersee-Symposium, Grenzgebiete zwischen HNO und Dermatologie; MAI 29, 2010; Klagenfurt. 2010.
[Keynote lecture]
Aberer, W
Diaklinik - diagnostische und therapeutische Fallstricke
"Fit in der Dermatologie"; MAI 7-9, 2010; Ramsau/Dachstein. 2010.
[Keynote lecture]
Aberer, W
Diagnose und Therapie des akuten und chronischen Ekzems
Fortbildungsabend der Steirischen Akademie für Allgemeinmedizin; MAR 3, 2010; Friesach. 2010.
[Keynote lecture]
Aberer, W
Von Pirquet bis zum Allergiechip
Frühjahrstagung der Österreichischen Gesellschaft für Dermatologie und Venerologie, Dermatologie in Zentraleuropa: stolze Vergangenheit, herausfordernde Zukunft, 1890-2010
; FEB 26, 2010; Wien. 2010.
[Keynote lecture]
Aberer, W
Klinik und Therapie von allergischen Erkrankungen in unterschiedlichen Lebensabschnitten was ist zu beachten bei Senioren?
5. Deutscher Allergiekongress; SEP 8-11, 2010; Hannover, DEUTSCHLAND. 2010.
[Keynote lecture]
Aberer, W
Der interessante Fall
Fortbildungssymposium für praktische Dermatologie und Venerologie; JUL 25-30, 2010; München, DEUTSCHLAND. 2010.
[Keynote lecture]
Aberer, W
Treating cutaneous HAE with Firazyr
Firazyr Case Studies Workshop; HAN 28-29, 2010; Amsterdam. 2010.
[Keynote lecture]
Aberer, W
Therapeutic options for bradykinin induced angioedema
9th ELS Symposium; Sep 1-4, 2010; Wien. 2010.
[Keynote lecture]
Aberer, W
Entzündliche Hauterkrankungen perianal
Fortbildungstagung der Österreichischen Akademie für Dermatologische Fortbildung; JUN 2-5, 2010; Bad Ischl. 2010.
[Keynote lecture]
Aberer, W
Verminderte Hautbarriere und ihre Bedeutung für die Langzeitbehandlung der atopischen Dermatitis
Fortbildungstagung der Österreichischen Akademie für Dermatologische Fortbildung; JUN 2-5, 2010; Bad Ischl. 2010.
[Keynote lecture]
Aberer, W
Atopische Dermatitis
Residents Forum der ÖADF; JUN 2, 2010; Bad Ischl. 2010.
[Keynote lecture]
Bokanovic, D; Aberer, W; Sturm, GJ
Der seltene Fall einer Lipid-Transfer-Protein assoziierten Typ I-Allergie in Österreich
ÖGDV - Jahrestagung 2010; NOV 19-21, 2010; Vienna, Austria. 2010.
[Poster]
Bokanovic, D; Aberer, W; Sturm, GJ
Pollenassoziierte Apfelallergie?
1. Wissenschaftliche Sitzung der Wissenschaftlichen Gesellschaft der Ärzte in der Steiermark; SEP 23, 2010; Graz, Austria. 2010.
[Oral Communication]
Bokanovic, D; Aberer, W; Sturm, GJ
Pollenassoziierte Apfelallergie? - Ein Fallbericht
15. Grazer Allergietag; SEP 25, 2010; Graz, Austria. 2010.
[Oral Communication]
Bokanovic, D; Laipold, K; Aberer, W; Sturm, GJ
The basophil activation test (BAT) compared to experimental and established diagnostic tools in grass pollen allergy
4th EuroBAT MEETING; OCT 31-SEP 1, 2010; Munich, Germany. 2010.
[Oral Communication]
Grims, R; Schuster, Ch; Rosskopf, K; Massone, C; Aberer, W
Gardner Diamond Syndrom
Wissenschaftliche Gesellschaft der Ärzte in der Steiermark; Okt 28, 2010; Graz. 2010.
[Oral Communication]
Richter, S; Revilla-Fernández, S; Plicka, H; Kranzelbinder, B; Aberer, W; Allerberger, F
Diagnosis of a human parapoxvirus infection in Austria, in 2010
29. AVID Tagung (Arbeitskreis Veterinärmedizinischge Infektionsdiagnostik)- Virologie; SEPT 15-17, 2010; Kloster Banz. 2010.
[Poster]
Schuster, C; Kränke, B; Aberer, W
Bufexamac-induced allergic contact dermatitis with generalization
Contact Dermatitis2010; 63: 81-81.-10th Congress of the European Society of Contact Dermatitis; SEP 15-18, 2010; Strasbourg, FRANCE.
[Poster]
Schuster, C; Kränke, B; Sturm, G; Aberer, W
Pravastatin-induced scrotal angioedema
12012010; -29th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology; JUN 5-9, 2010; London, UNITED KINGDOM.
[Poster]
Schuster, C; Wolf, P; Becker JC; Aberer W; Massone C
Thrombangiitis obliterans: Kombinationstherapie von Iloprost und Thrombozytenaggregationshemmer
S 662010; -Jahrestagung der Österreichischen Gesellschaft für Dermatologie und Venerologie; NOV 19-21, 2010; Wien.
[Poster]
Sturm, GJ; Kranzelbinder, B; Schuster, C; Sturm, E; Vollmann, J; Heinemann, A; Crailsheim, K; Aberer, W
Sting challenges in asymptomatically sensitized subjects to hymenoptera venom: increased specific IgE levels after sting challenges are not a risk factor for future systemic reactions.
Allergy2010; -29th Congress of the European Academy of Allergy and Clinical Immunology; June 5-9, 2010; London, Great Britain.
[Oral Communication]
Varga, EM; Francis, J; Wong, C; Zach, M; Aberer, W
Repeated allergen exposure during beekeeping and venom immunotherapy induces venom-specific serum inhibitory activity for IgE-facilitated antigen binding(igE-FAB) in parallel with elevated venom-specific igG4 antibodies
Allergy2010; 65(s92):78-208.-European Academy of Allergy and Clinical Immunology; June, 9-12- 2010; London,UK.
[Poster]
Wiednig, M; Kleinert, R; Kranzelbinder, B; Weger, W; Aberer, W; Cerroni, L
Kutane kollagenöse Vasculopathie
Jahrestagung der Österreichischen Gesellschaft für Dermatologie und Venerologie ; NOV 19-21, 2010; Vienna, AUSTRIA . 2010.
[Poster]
Aberer, W
Rare Contact allergens - rare or rarely recognized?
ALLERGOLOGIE. 2009; 32(10):411-411.-Neue Allergene; NOV 15-16, 2009; Bad Saarow.
[Oral Communication]
Web of Science
Aberer, W
Efficacious treatment of subsequent hereditary angioedema attacks with Icatibant, a Bradykinin B2 receptor antagonist: Results from the open-label extension phase of the fast trials
10 Int Congress Dermatology; MAY 20-24, 2009; Prag, Tschechien. 2009.
[Poster]
Aberer, W
Treatment of subsequent hereditary angioedema attacks with Icatibant
10. Int. Congress of Dermatology; MAY 20-23, 2009; Prag, Tschechien. 2009.
[Oral Communication]
Aberer, W
Allergies as environmental disease?
Immuntoxikologiekurs; JUL 2-3, 2009; Wien, AUSTRIA. 2009.
[Oral Communication]
Aberer, W
Introduction to allergy
Immuntoxikologiekurs; JUL 2-3, 2009; Wien, AUSTRIA. 2009.
[Oral Communication]
Aberer, W
firazyr in HAE - situation analysis
Fachtagung Firazyr; APR 17, 2009; Wien, AUSTRIA. 2009.
[Oral Communication]
Aberer, W
The natural history of food allergy
18th Congress of the EADV; OCT 7-11, 2009; Berlin, Deutschland. 2009.
[Oral Communication]
Aberer, W
Role of allergy testing in dermatology.
Int. postgraduate Course at the 7th Golnick-Symposium; OCT 2-3, 2009; Bled, Slowenien. 2009.
[Oral Communication]
Aberer, W
Kontaktallergien auf Kosmetika
4. Gemeinsamer Deutscher Allergiekongress; SEP 4-6, 2009; Berlin, Deutschland. 2009.
[Oral Communication]
Aberer, W
General provocation test protocol for other drugs
Allergy school der EAACI; JUL 24-26, 2009; Fischbachau, Deutschland. 2009.
[Oral Communication]
Aberer, W
Allergien gegen Topika
25. Jenaer Allergologikum zu Unverträglichkeit von Arzneimittel - immer allergisch?; MAY 9, 2009; Jena, Deutschland. 2009.
[Oral Communication]
Aberer, W
Hereditary angioedema: Clinic - treatment - new treatment
Fortbildungstagung des Uni-Klinikums Lissabon; JAN 12, 2009; Lissabon, PORTUGAL. 2009.
[Keynote lecture]
Aberer, W
Aus der berufsdermatologischen Praxis
AUVA-Sicherheitsexpertentagung; NOV 19, 2009; Graz, AUSTRIA. 2009.
[Oral Communication]
Aberer, W
Diagnose und Therapie des akuten und chronischen Ekzems
Fortbildungsveranstaltung der Ärztekammer Burgenland; Jan 14, 2009; Heiligenkreuz. 2009.
[Keynote lecture]
Aberer, W
Aerogenes Kontaktekzem
45. Tagung der Deutschen Dermatologischen Gesellschaft; APR 29- MAY 2, 2009; Dresden, Deutschland. 2009.
[Oral Communication]
Aberer, W
Clinics of allergic diseases, diagnostics and therapy
Immuntoxikologiekurs; JUL 2-3, 2009; Wien, AUSTRIA. 2009.
[Oral Communication]
Aberer, W
Volkskrankheit Neurodermitis - Heilung in Sicht?
Minimed-Studium; MAY 28, 2009; Graz, AUSTRIA. 2009.
[Keynote lecture]
Aberer, W
Spezifische Immuntherapie: Nachweis der Wirksamkeit früher und heute
4. Gemeinsamer Deutscher Allergiekongress; SEP 4-6, 2009; Berlin, Deutschland. 2009.
[Oral Communication]
Aberer, W
How to interpret patch tests
6th EADV Spring Symposium; APR 23-26, 2009; Bukarest, Rumänien. 2009.
[Oral Communication]
Aberer, W
Aktuelle Aspekte zur SIT unter besonderer Berücksichtigung des hypoallergenen Prinzips
Fortbildungsveranstaltung des LKH St. Pölten; Feb 10, 2009; St. Pölten. 2009.
[Keynote lecture]
Aberer, W
Pearls and pitfalls
Fortbildungstage der ÖADF; JUN 11-13, 2009; Mondsee, AUSTRIA. 2009.
[Oral Communication]
Aberer, W
Fallstricke bei Kontaktallergie
12. Innsbrucker Allergiegespräche; MAr 28, 2009; Innsbruck, Austria. 2009.
[Oral Communication]
Aberer, W
HAE, overview
1. Nordic Bradykinin Workshop; DEC 4, 2009; Kopenhagen, Dänemark. 2009.
[Oral Communication]
Aberer, W
Aktuelle Entwicklungen des dermatologischen Qualitätsmanagements in Österreich
Jahrestagung der Kommission Qualitätssicherung der Deutschen Dermatologischen Gesellschaft und des BVDD; OCT 31, 2009; München, Deutschland. 2009.
[Oral Communication]
Aberer, W
Möglichkeiten der spezifischen Immuntherapie
22. Allergie-Kolloquium des Forschungszentrum Borstel; MAY 16, 2009; Borstel, Deutschland. 2009.
[Oral Communication]
Aberer, W
Kunst in der Dermatologie
Urania - Fortbildungsveranstaltung; SEP 30, 2009; Graz, AUSTRIA. 2009.
[Oral Communication]
Aberer, W
Testing of substances in humans for allergenic potency
Immuntoxikologiekurs; JUL 2-3, 2009; Wien, AUSTRIA. 2009.
[Oral Communication]
Aberer, W
Leitlinien: Übel oder Notwendigkeit?
Fortbildungstagung der ÖADF; JUN 11-13, 2009; Mondsee, AUSTRIA. 2009.
[Oral Communication]
Aberer, W
Casus pro diagnosi - Soja
ÖGAI - rekombinante Allergene; APR 16-17, 2009; Wien, AUSTRIA. 2009.
[Oral Communication]
Aberer, W
Allergische Erkrankungen
Fortbildungswochenende für Dermatologen; Jan 23, 2009; Pichlarn. 2009.
[Keynote lecture]
Aberer, W
How to make a correct diagnosis of drug allergy
18th Congress of the EADV; OCT 7-11, 2009; Berlin, Deutschland. 2009.
[Oral Communication]
Aberer, W
Differential diagnosis of allergic skin disease: eczema/dermatitis
Proceedings2009; -28. Kongress der Europäischen Akademie für Allergie und Immunologie; JUN 6-10, 2009; Warschau, Polen.
[Oral Communication]
Aberer, W
Eduard Lipp, progenitor of the German Society of Dermatology
18th Congress of the EADV; OCT 7-11, 2009; Berlin, Deutschland. 2009.
[Oral Communication]
Aberer, W
Kontaktekzem
Resident´s Forum der ÖADF; NOV 26, 2009; Salzburg, AUSTRIA. 2009.
[Oral Communication]
Aberer, W
Das neue Unkraut Ambrosia gefährdet unsere Landwirtschaft und Gesundheit
Veranstaltung der Landwirtschaftskammer Steiermark und der AGES; Mar 12, 2009; Deutsch Goritz. 2009.
[Keynote lecture]
Aberer, W
Clinical efficacy and safety profile of Firazyr: Results from FAST trials
Firazyr HAE Autumn Symposium; NOV 20-21, 2009; Barcelona, Spanien. 2009.
[Oral Communication]
Aberer, W
What are allergens, which allergens are relevant?
Immuntoxikologiekurs; JUL 2-3, 2009; Wien, AUSTRIA. 2009.
[Oral Communication]
Aberer, W
Herpes - HPV
43. Wissenschaftliche Fortbildungswoche für Apotheker; MAR 1-6, 2009; Saalfelden. 2009.
[Oral Communication]
Aberer, W
Contact eczema and contact urticaria
Immuntoxikologiekurs; JUL 2-3, 2009; Wien, AUSTRIA. 2009.
[Oral Communication]
Aberer, W
Topische Basistherapie bei chronischen Dermatosen - ein vernachlässigtes Stiefkind
Jahrestagung der ÖGDV; NOV 26-28, 2009; Salzburg, AUSTRIA. 2009.
[Oral Communication]
Aberer, W
HAE 2009
HAE-Expertenmeeting; SEP 18-19, 2009; Salzburg, AUSTRIA. 2009.
[Oral Communication]
Aberer, W; Horak, F; Fischer von Weikersthal-Drachenberg, KJ
Europäische Ergebnisse von Patienten mit allergischer Rhinokonjunktivitis in einer Placebo-kontrollierten Studie zur subkutanen Ultrakurzzeit-Immuntherapie
4. Gemeinsamer Deutscher Allergiekongress; SEP 4-6, 2009; Berlin, Deutschland. 2009.
[Poster]
Aberer, W; von Weikersthal-Drachenberg, F
European outcomes amongst allergic Rhinoconjunctivitis patients participating in a placebo-controlled study of ultra short course subcutaneous immunotherapy (uSCIT) conducted during the 2007 grass pollen season
ALLERGY. 2009; 64: 527--28th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology; JUN 06-10, 2009; Warsaw, POLAND.
[Poster]
Web of Science
Geroldinger-Simic, M; Zelniker, T; Aberer, W; Ebner, C; Egger, C; Greiderer, A; Prem, N; Lidholm, J; Gubesch, M; Vieths, S; Bohle, B
Epidemiological and immunological aspects of birch pollen-related food allergy: possible involvement of IgG4 antibodies in tolerance
ALLERGY. 2009; 64: 607--28th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology; JUN 06-10, 2009; Warsaw, POLAND.
[Oral Communication]
Web of Science
Glatz, M; Degen, D; Aberer, W; Müllegger, RR
Das Erysipel in atypischer Lokalisation: klinische Charakteristika und Risikofaktoren
Jahrestagung der ÖGDV; NOV 27-29, 2009; Salzburg, Österreich. 2009.
[Poster]
Harrer, A; Grims, R; Hawranek, T; Lang, R; Kinaciyan, T; Vogel, L; Aberer, W; Ferreira, F; Himly, M
Lessons from drug allergy - how to investigate severe type I-like hypersensitivity reactions
7th EAACI Ga2len Winter School for Basic Immunology; FEB 5-8, 2009; Davos, Schweiz. 2009.
[Poster]
Harrer, A; Grims, R; Hawranek, T; Lang, R; Lothar, V; Aberer, W; Fatima, F; Himly, M
Severe type I-like hypersensitivity reactions to diclofenac involve allergic effector cells independent of IgE
ALLERGY. 2009; 64: 1070--28th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology; JUN 06-10, 2009; Warsaw, POLAND.
[Oral Communication]
Web of Science
Komericki, P; Klein, G; Reider, N; Hawranek, T; Lang, R; Strimitzer, T; Kranzelbinder, B; Aberer, W
Histamine-intolerance and orally administered diaminoxidase: results of a multicenter-study
J DTSCH DERMATOL GES. 2009; 7: 203-204.
[Poster]
Web of Science
Kranzelbinder, B; Schuster, C; Aberer, W; Sturm, G
Hymenoptera venom immunotherapy: comparison of different updosing regimes regarding side effects and efficacy
ALLERGY. 2009; 64: 1197--28th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology; JUN 06-10, 2009; Warsaw, POLAND.
[Poster]
Web of Science
Kranzelbinder, B; Sturm, E; Vollmann, J; Aberer, W; Heinemann, A; Crailsheim, K; Sturm, GJ
Patienten mit asymptomatischer Sensibilisierung auf Insektengifte: Geringes Risiko einer zukünftigen systemischen Stichreaktion.
Abstractband2009; -Jahrestagung der ÖGDV; NOV 27-29, 2009; Salzburg, AUSTRIA.
[Poster]
Mittermann, I; Zidarn, M; Silar, M; Markovic-Housley, Z, Aberer, W; Korosec, P, Kosnik, M; Valenta, R
Recombinant allergen-based diagnostic tests to dissect bee and wasp allergy
3. World Allergy Congress; DEC 6-12, 2009; Buenos Aires, Argentinien. 2009.
[Poster]
Schuster, C; Kranke, B; Aberer, E; Arbab, E; Sturm, G; Aberer, W
Schnitzler syndrome: response to anakinra in two cases and a review of the literature
ALLERGY. 2009; 64: 1366--28th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology; JUN 06-10, 2009; Warsaw, POLAND.
[Poster]
Web of Science
Schuster, C; Kränke, B; Aberer, W; Komericki, P
Penile fixe Arzneimittelreaktion durch Oxcarbazepin
102-1022009; -Jahrestagung der Österreichischen Gesellschaft für Dermatologie und Venerologie; NOV 27-29, 2009; Salzburg, AUSTRIA.
[Poster]
Schuster, C; Kränke, B; Reiter, H; Augustin, H; Aberer, W
Pravastatin-induced scrotal edema
P69; 2009; -Congress of the European Academy of Dermatology and Venereology; OCT 7-11, 2009; Berlin, GERMANY.
[Poster]
Sturm, G; Kranzelbinder, B; Schuster, C; Sturm, E; Heinemann, A; Aberer, W
Correlation of the basophil activation test (BAT) and routine diagnostic tools with the outcome of sting challenges in asymptomatically sensitised subjects to hymenoptera venom
ALLERGY. 2009; 64: 81--28th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology; JUN 06-10, 2009; Warsaw, POLAND.
[Oral Communication]
Web of Science
Aberer, W
Repeated hereditary angioedema attacks can be effectively treated with the selective, potent bradykinin B-2 receptor antagonist Icatibant
ALLERGY. 2008; 63: 474-474.
[Poster]
Web of Science
Arbab, E; Schuster, C; Aberer, W; Kraenke, B
AUSPICIOUS THERAPY IN SCHNITZLER'S SYNDROME
Abstract - Konferenzband2008; -The Annual Congress of the European Academy of Dermatology Venereology ; SEPT 17-21, 2008; Paris, FRANCE.
[Poster]
Geroldinger-Simic, M; Zelniker, T; Aberer, W; Ebner, C; Egger, C; Greiderer, A; Prem, N; Bohle, B
The role of allergen-specific IgG4 antibodies in birch pollen-associated food allergies
WIEN KLIN WOCHENSCHR. 2008; 120: 136-136.
[Oral Communication]
Web of Science
Grims, RH; Weger, W; Reiter, H; Kranke, B; Aberer, W
Non IgE-interfered incompatibility reaction from straight type against steroid
ALLERGOLOGIE. 2008; 31(5):187-187.
[Oral Communication]
Web of Science
Grims, RH; Weger, W; Reiter, H; Kränke, B; Aberer, W
Nicht IgE-vermittelte Unverträglichkeitsreaktion vom Soforttyp gegen Steroide.
Dermatologie in Beruf und Umwelt2008; 56(2):78-78.-8: Dermatologisches Alpenseminar. Allergologie, Berufs- und Umweltdermatologie. ; MAY 1-4, 2008 ; Grainau/Zugspitzendorf, Germany.
[Oral Communication]
Jurilj, M; Schuster, C; Fruhauf, J; Horn, T; Aberer, W; Sturm, G
Patients' compliance during specific allergen immunotherapy - frequency of dropouts and underlying reasons
ALLERGY. 2008; 63: 146-146.-Congress of the European Academy of Allergology and Clinical Immunology; JUNE 7-11, 2008; Barcelona, SPAIN.
[Poster]
Web of Science
Komericki, P; Klein, G; Hawranek, T; Land, R; Reider, N; Strimitzer, T; Kranzelbinder, B; Aberer, W
Oral dose diamine oxidase (DAO) in patients with suspicion on Histamine-intolerance
ALLERGOLOGIE. 2008; 31(5):190-190.
[Oral Communication]
Web of Science
Kranzelbinder, B; Schuster, C; Frühauf, J; Groselj-Strele, A; Aberer, W; Sturm, GJ
Der Basophilen-Aktivierungstest (BAT) als diagnostische Methode in der Insektengiftallergie: Sensitivität, Spezifität und Einflussfaktoren
Allergo J. 2008; 17 (Suppl 1): 9--8. Arbeitsgespräch Insektengiftallergie; JUNE 20-21, 2008; Bayreuth, GERMANY.
[Oral Communication]
Kranzelbinder, B; Schuster, C; Frühauf, J; Laipold, K; Groselj-Strele, A; Aberer, W; Sturm, G
The basophil activation test (BAT) in Hymenoptera allergy - sensitivity, specificity and influencing factors on the test results
ALLERGY. 2008; 63: 25-25.-Congress of the European Academy of Allergology and Clinical Immunology; JUNE 7-11, 2008; Barcelona, SPAIN.
[Oral Communication]
Web of Science
Schuster, C; Kränke, B; Arbab, E; Aberer, E; Sturm, GJ; Aberer, W
Schnitzler Syndrom: Prompter Therapieerfolg unter Anakinra und Literaturübersicht.
Abstract-Konferenzband2008; -Jahrestagung der ÖGDV; NOV 30 - DEC 2, 2008; Vienna, AUSTRIA.
[Poster]
Schuster, C; Sturm, G; Aberer, W; Kranke, B
Cutaneous adverse effects to EGFR-targeted agents
ALLERGY. 2008; 63: 372-372.-Congress of the European Academy of Allergology and Clinical Immunology; JUNE 7-11, 2008; Barcelona, SPAIN.
[Poster]
Web of Science
Sturm, G; Jin, C; Hemmer, W; Kranzelbinder, B; Focke, M; Altmann, F; Aberer, W
Double sensitisation in Hymenoptera venom allergy: comparison of western blot IgE binding patterns with results from skin testing, serum IgE determination, and basophil activation test
ALLERGY. 2008; 63: 12-13.-Congress of the European Academy of Allergology and Clinical Immunology; JUNE 7-11, 2008; Barcelona, SPAIN.
[Oral Communication]
Web of Science
Sturm, GJ; Jin, C; Hemmer, W; Kranzelbinder, B; Focke, M; Altmann, F; Aberer, W
Doppelsensibilisierungen in der Insektengiftallergie - Vergleich von IgE Mustern im Western Bot mit den Ergebnissen von Hauttest, IgE Bestimmung und Basophilen-Aktivierungstest
Allergo J 2008; 17 (Suppl 1): 9.2008; -8. Arbeitsgespräch Insektengiftallergie; JUNE 20-21, 2008; Bayreuth, GERMANY.
[Oral Communication]
Varga, EM; Francis JN, Wong C, Zach MS, Aberer W, Durham SR
Bee venom immunotherapy inhibits facilitated antigen presentation during treatment but not after withdrawal
Clin Exp Allergy2008; 2008(38):1978-1995.-Annual Conference British Society for Allergy and Clinical Immunology
; 14.7.-16.7.2008; Loughborough,UK.
[Poster]
Grims, RH; Kränke, B; Weger, W; Komericki, P; Aberer, W
Spättypallergie auf Heparine- abhängig vom Molekulargewicht?
Abstractband der ÖGDV2007; 54-54.-Jahrestagung der Österreichischen Gesellschaft für Dermatologie und Venerologie; NOV 30- DEC 2, 2007; Vienna, Austria.
[Poster]
Komericki, P; Grims, RH; Kränke, B; Aberer,W
Akute generalisierte exanthematische Pustulose auf Dalteparin.
Abstractband der ÖGDV2007; 62-62.-Jahrestagung der Österreichischen Gesellschaft für Dermatologie und Venerologie; NOV 30-DEC 2, 2007; Vienna, AUSTRIA.
[Poster]
Schuster, C; Kranke, B; Sturm, G; Reiter, H; Aberer, W
Occupational dermatitis from isothiazolinones in a metalworking fluid
ALLERGY. 2007; 62: 93-94.
[Poster]
Web of Science
Schuster, C; Sturm, GJ; Aberer, W; Kränke, B
Akne im Erwachsenenalter.
12. Grazer Allergietag; SEPT 22, 2007; Graz, AUSTRIA. 2007.
[Oral Communication]
Sturm, GJ; Grims, R; Schuster, C; Flieser, N; Freistätter, I; Wiednig, M; Aberer, W
Double sensitization in Hymenoptera venom allergy: The basophil activation test (BAT) compared to established diagnostic tools.
Allergy 2007; 62(s83):13--26th Congress of the European Academy of Allergy and Clinical Immunology ; JUNE 9-13, 2007; Göteborg, Sweden.
[Oral Communication]
Web of Science
Sturm, GJ; Schuster, C; Grims, R; Aberer, W
Irrelevante Doppelsensibilisierungen in der Insektengiftallergie - Der Basophilen-Aktivierungstest (BAT) im Vergleich zu etablierten diagnostischen Methoden.
Abstractband der ÖGDV2007; 80-80.-Jahrestagung der Österreichischen Gesellschaft für Dermatologie und Venerologie; NOV 30 - DEC 2, 2007; Vienna, AUSTRIA.
[Poster]
Varga, E; Zach, M; Klunker, S; Aberer, W; Durham, S; Francis, J
Inhibition of facilitated antigen presentation by venom immunotherapy in children
ALLERGY. 2007; 62: 73-74.
[Poster]
Web of Science
Aberer, W
Desloratadine for the relief of nasal and non-nasal allergic symptoms: an observational study
J ALLERG CLIN IMMUNOL. 117: S320-S321.-62nd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology; MAR 03-07, 2006; Miami Beach, FL.
Doi: 10.1016/j.jaci.2005.12.1265
[Poster]
Web of Science
FullText
FullText_MUG
Aberer, W
Management of Drug Hypersensitivity
2nd Int. Meeting on Drug Hypersensitivity; APR 18-21, 2006; Liverpool, UK. 2006.
[Oral Communication]
Aberer, W
Kontaktallergene
29. Kongress des Ärzteverbandes deutscher Allergologen; SEP 16-16, 2006; Wiesbaden, GERMANY. 2006.
[Oral Communication]
Aberer, W
Patch test course: Assessment of Clinical Relevance
8th Congress of the European Society of Contact Dermatitis; SEP 16-16, 2006; Berlin, GERMANY. 2006.
[Oral Communication]
Aberer, W
Contact allergy and medicinal herbs
Annual Meeting of the European Academy of Dermatology and Venerology; OCT 4-8, 2006; Rhodos, GREECE. 2006.
[Oral Communication]
Aberer, W
Fallstricke bei der Bewertung des Epikutantests
8th Congress of the European Society of Contact Dermatitis; SEP 13-16, 2006; Berlin, GERMANY. 2006.
[Oral Communication]
Aberer, W
Problems and pitfalls in the diagnosis of Drug Hypersensitivity
25th European Academy of Allergy and Clinical Immunology; JUN 10-14, 2006; Vienna, AUSTRIA. 2006.
[Oral Communication]
Aberer, W
Contact Dermatitis
Ga2len Summer School of the EAACI; Sep 30-Oct 2, 2006; Hannover, GERMANY. 2006.
[Oral Communication]
Aberer, W
Kontaktallergien auf Berufsstoffe - Relevanz von Hautreaktionen im Epikutantest
8. Internationaler Hautschutztag; MAI 16-17, 2006; Krefeld, GERMANY. 2006.
[Keynote lecture]
Aberer, W
From national briefings towards an European HAE-perspective; country specific presentations and short discussions: The situation in Austria.
International Advisory Board-Meeting of Icatibant ; FEB 17, 2006; Berlin, DEUSCHLAND. 2006.
[Oral Communication]
Aberer, W
Diagnostic measures in chronic hand dermatitis.
Expert workshop on severe chronic hand dermatitis; JAN 19, 2006; Hamburg, GERMANY. 2006.
[Oral Communication]
Aberer, W
How to cope with side effects of specific immunotherapy?
25th European Academy of Allergy and Clinical Immunology; JUN 10-14, 2006; Vienna, AUSTRIA. 2006.
[Oral Communication]
Arbab, E; Aberer, W; Kränke, B
Erythema multiforme-like eruption triggered by patch test with bufexamac
-XXV Congress of the European Academy of Allergology and Clinical Immunology; 10.6. 14.6.2006 ; Wien.
[Poster]
Arbab, E; Schintler, MV; Aberer, W
Chronische Wunde und Tetanus
-Jahrestagung der Österreichischen Gesellschaft für Dermatologie und Venerologie; 24.11.-26.11.2006; Salzburg.
[Oral Communication]
Schuster, C; Kränke, B; Sturm, G; Aberer, W
Angioödem unter Angiotensin-II-Rezeptor Antagonist Eprosartan.
Jahrestagung 2006 der Österreichischen Gesellschaft für Dermatologie und Venerologie (ÖGDV); Nov 24-26, 2006; Salzburg, AUSTRIA. 2006.
[Poster]
Sturm, GJ; Schuster, C; Wiednig, M; Strele, A; Aberer, W
Erhöhte basale Tryptasewerte bei Insektengiftallergikern ¿ Generell ein Risikofaktor für schwere Stichreaktionen?
-Jahrestagung der Österreichischen Gesellschaft für Dermatologie und Venerologie; NOV 24-26, 2006; Salzburg, Austria.
[Oral Communication]
Sturm, GJ; Wiednig, M; Strele, A; Schuster, C; Aberer, W
Baseline serum tryptase levels and the severity of sting reactions in Hymenoptera venom allergy.
-25th European Academy of Allergy and Clinical Immunology Congress; JUN 10-14, 2006; Vienna, AUSTRIA.
[Oral Communication]
Sturm, GJ; Wiednig, M; Strele, A; Schuster, C; Aberer, W
Baseline serum tryptase levels and the severity of sting reactions: Further considerations
Abstract book 2006; 48--XXV Congress of the European Academy of Allergology and Clinical Immunology; JUN 10-14, 2006; Vienna, AUSTRIA.
[Oral Communication]
Sturm, GJ; Schuster, C; Trummer, M; Aberer, W
Bedeutung und Nutzen der Gesamt-IgE Bestimmung in der Diagnose der Insektengiftallergie
Allergo Journal Sonderheft 2005; -7. Arbeitsgespräch Insektengiftallergie; SEP 23-24, 2005; Regensburg, GERMANY.
[Oral Communication]
Sturm, GJ; Schuster, C; Trummer, M; Sturm, E; Aberer, W
Correlation between asymptomatic sensitization and total IgE levels in non-insect venom allergic patients.
2005; -World Allergy Congress; JUN 26 - JUL 1, 2005; Munich, GERMANY.
[Poster]
Laimer, M; Klausegger, A; Aberer, W; Wally, V; Lanschuetzer, CM; Hintner, H; Bauer, JW
Hereditary angioedema in consequence of a 150 bp deletion in the 3 ' UTR of C1-inhibitor gene
J INVEST DERMATOL 2004 123: 104-104.
Web of Science
Sturm, GJ; Schuster, C; Trummer, M; Aberer, W
The impact of total IgE in the diagnosis of Hymenoptera venom allergy.
2004; -XXIII EAACI Congress; JUNE 12-16, 2004; Amsterdam, NETHERLANDS.
[Oral Communication]
Sturm, GJ; Schuster, C; Trummer, M; Kränke, B; Aberer, W
Bedeutung und Nutzen der Gesamt-IgE Bestimmung in der Diagnose der Insektengiftallergie.
2004; -ÖGDV Jahrestagung; DEC 3-5, 2004; Graz, AUSTRIA.
[Oral Communication]
Sturm, GJ; Böhm, E; Williams, TJ; Peskar, BA; Hartnell, A; Aberer, W; Heinemann, A
The role of stem cell factor in the regulation of human basophils: Selective enhancement of chemotaxis and CD11b up-regulation.
2003; -ÖGAI Jahrestagung; DEC 4-6, 2003; Salzburg, AUSTRIA.
[Poster]
Sturm, GJ; Heinemann, A; Aberer, W
Der Basophilen - Aktivierungstest (BAT) im Vergleich zu Hauttest und spezifischem IgE
2003; -ÖGDV Jahrestagung; NOV, 21-23, 2003; Graz, AUSTRIA.
[Oral Communication]
Grims, RH; Aberer, W; Kränke, B
Generalisierte Urtikaria nach intraartikulärer Steroidgabe: Steroidallergie ?
7. Grazer Allergietag; NOV 23, 2002; Graz, AUSTRIA. 2002.
[Poster]
Sturm, G; Kränke, B; Aberer, W
Rush, Ultrarush, Maximarush - ein sinnvoller Wettlauf? Ein Aufruf zu vereinheitlichten gemeinsamen Schemata
Allergo Jounal Sonderhheft 2002; -6. Arbeitsgespräch Insektengiftallergie; JUN 21-22, 2002; Weimar, GERMANY.
[Oral Communication]
Sturm, GJ; Heinemann, A; Aberer W
Immuntherapie bei Insektengiftallergie: Konventionell, schnell, ultraschnell?
ÖGDV Jahrestagung; NOV 15-17, 2002; Vienna, AUSTRIA. 2002.
[Oral Communication]
Grims, R; Remler, P; Woltsche-Kahr, I; Pfannhauser, W; Aberer, W
DBPCFC with tasty recipes for 8 allergenic foods.
8th International Symposium on Immunological, Chemical and Clinical Problems of Food Allergy; MAR 11-13, 2001; Venezia, Italy. 2001.
[Poster]
GENSER, D; LOCHS, H; WOTAPEK, A; HEINZL, H; ABERER, W
SERUM ANTIBODIES TO FOOD ANTIGENS IN PATIENTS WITH CROHNS-DISEASE - IMPORTANCE OF INTESTINAL PERMEABILITY
GASTROENTEROLOGY. 1994; 106(4): A1028-A1028.
Web of Science
WANG, BH; RIEGER, A; WANEK, P; ABERER, W; WOLFF, K; STINGL, G
HETEROGENEITY OF IGE-BEARING CELLS IN LESIONAL SKIN OF ATOPIC-DERMATITIS PATIENTS
J INVEST DERMATOL. 1990; 95(4): 495-495.
Web of Science
JARISCH, R; GOTZ, M; ABERER, W
SIDE-EFFECTS OF SPECIFIC IMMUNOTHERAPY, REDUCTION BY PRETREATMENT WITH ANTIHISTAMINS
J ALLERG CLIN IMMUNOL. 1988; 81(1): 262-262.
Doi: 10.1016/0091-6749(88)90609-4
Web of Science
FullText
FullText_MUG
ABERER, W; KATZ, SI
INVIVO EFFECTS OF ANTI-I-A ANTIBODIES ON THE INDUCTION AND EXPRESSION OF CONTACT SENSITIVITY
J INVEST DERMATOL. 1986; 86(3): 325-325.
Web of Science
ABERER, W; LEIBL, H; STINGL, G
EFFECT OF UV-B RADIATION ON THE BIOSYNTHESIS OF HLA-DR ANTIGENS
J INVEST DERMATOL. 1986; 87(1): 127-127.
Web of Science
PEHAMBERGER, H; GROH, V; LEIBL, H; TANI, M; ABERER, W; LISZKA, C; VETTERLEIN, M; WOLFF, K
GANGLIOSIDE DETERMINANTS ON MELANOMA AND NEVUS CELLS
J INVEST DERMATOL. 1986; 87(1): 161-161.
Web of Science
SZAFER, F; TZFONI, E; SHERMAN, L; HACHAMZADEH, S; ABERER, W; TAPPEINER, G; HOLUBAR, K; STEINMAN, L; FRIEDMAN, A; BRAUTBAR, C
HLA IN PEMPHIGUS VULGARIS INVESTIGATED ON THE SEROLOGICAL, CELLULAR AND GENOMIC LEVEL
J INVEST DERMATOL. 1986; 87(1): 170-170.
Web of Science
ABERER, W
PYODERMA-GANGRAENOSUM
HAUTARZT. 1985; 36(5): 307-307.
Web of Science
ABERER, W; KRUISBEEK, AM; SHIMADA, S; KATZ, SI
MODULATION OF ANTIGEN PRESENTING CELL-FUNCTION BY INVITRO ADMINISTRATION OF ANTI-IA ANTIBODIES
J INVEST DERMATOL. 1985; 84(4): 355-356.
Web of Science
ABERER, W; ROMANI, N; ELBE, A; STINGL, G
DIFFERENTIAL-EFFECTS OF VARIOUS PHYSICOCHEMICAL AGENTS ON IA-1-POSITIVE EPIDERMAL-CELLS
ARCH DERMATOL RES. 1985; 277(5): 431-431.
Web of Science
ABERER, W; STINGL, G
EFFECTS OF PHYSICOCHEMICAL AGENTS ON IA-1 AND THY-1 POSITIVE EPIDERMAL-CELLS
J INVEST DERMATOL. 1984; 82(4): 417-417.
Web of Science
ABERER, W; STINGL, G
EFFECTS OF PHYSICOCHEMICAL AGENTS ON IA-1 AND THY-1 POSITIVE EPIDERMAL-CELLS
CLIN RES. 1984; 32(2): A567-A567.
Web of Science
PEHAMBERGER, H; ABERER, W; VOLCPLATZER, D; MAJDIC, O; KNAPP, W; STINGL, G; WOLFF, K
HLA-DR (IA-LIKE) ANTIGEN SYNTHESIS AND EXPRESSION ON NODULAR MELANOMA
ARCH DERMATOL RES. 1984; 276(4): 268-268.
Web of Science
TSCHACHLER, E; TANI, M; ABERER, W; WOLFF, K; STINGL, G
A MONOCLONAL-ANTIBODY TO MOUSE HEAT-STABLE ANTIGEN - A SELECTIVE MELANOCYTE MARKER IN HUMAN-EPIDERMIS
J INVEST DERMATOL. 1984; 82(5): 543-543.
Web of Science
ABERER, W; STINGL, LA; POGANTSCH, S; STINGL, G
EFFECTS OF GLUCOCORTICOSTEROIDS ON EPIDERMAL LANGERHANS CELLS - IMMUNOHISTOLOGIC AND FUNCTIONAL-STUDIES
ARCH DERMATOL RES. 1983; 275(4): 279-279.
Web of Science
ABERER, W; STINGL, LA; POGANTSCH, S; STINGL, G
EFFECTS OF GLUCOCORTICOSTEROIDS ON ANTIGEN PRESENTING CELLS
J INVEST DERMATOL. 1983; 80(4): 309-309.
Web of Science
HONIGSMANN, H; SCHULER, G; ABERER, W; WOLFF, K
IMMEDIATE PIGMENT DARKENING - A REEVALUATION OF PROPOSED MECHANISMS
J INVEST DERMATOL. 1983; 80(4): 367-368.
Web of Science
MAJDIC, O; ABERER, W; BETTELHEIM, P; LISZKA, K; KNAPP, W
MONOCLONAL-ANTIBODIES AGAINST MYELOID DIFFERENTIATION ANTIGENS
BLUT. 1982; 45(3): 189-190.
Web of Science
SCHULER, G; STINGL, G; ABERER, W; STINGLGAZZE, LA; HONIGSMANN, H; WOLFF, K
DEMONSTRATION OF IA ANTIGENS ON HISTIOCYTOSIS X-CELLS
ARCH DERMATOL RES. 1982; 273(1-2): 179-179.
Web of Science
ABERER, W; STINGL, G; GAZZE, LA; WOLFF, K
LOSS OF ALLOGENIC AND SYNGENIC STIMULATION OF T-CELL PROLIFERATION IN EPIDERMAL-CELLS AFTER UV-B-RADIATION
MED WELT. 1981; 32(17): 675-675.
Web of Science
ABERER, W; STINGL, G; GAZZE, LA; WOLFF, K
EFFECTS OF ULTRAVIOLET-LIGHT (UV) ON IMMUNOLOGICAL FUNCTIONS OF EPIDERMAL-CELLS - UV-B ABROGATES THE CAPACITY OF EPIDERMAL-CELLS TO STIMULATED SYNGENEIC AND ALLOGENEIC T-CELL PROLIFERATION
ARCH DERMATOL RES. 1981; 270(2): 231-231.
Web of Science
ABERER, W; STINGL, G; STINGLGAZZE, LA; WOLFF, K
UV-INDUCED ABROGATION OF THE MURINE LANGERHANS CELL-LYMPHOCYTE REACTION
J INVEST DERMATOL. 1981; 76(5): 414-414.
Web of Science
BELTER, S; ABERER, W; STINGLGAZZE, LA; WOLFF, K; SCHULER, G; STINGL, G
A NEW METHOD FOR LANGERHANS CELL ENRICHMENT
J INVEST DERMATOL. 1981; 76(5): 427-427.
Web of Science
SCHULER, G; ABERER, W; HONIGSMANN, H; STINGL, G
UV-INDUCED DAMAGE OF EPIDERMAL LANGERHANS CELLS
J CUTANEOUS PATHOL. 1981; 8(2): 156-156.
Web of Science
STINGL, G; GAZZE, LA; ABERER, W; WOLFF, K
EFFECTS OF ULTRAVIOLET-LIGHT (UV) ON IMMUNOLOGICAL FUNCTIONS OF EPIDERMAL-CELLS .2. UV-B-INDUCED IMPAIRMENT OF ANTIGEN-PRESENTING FUNCTION OF EPIDERMAL-CELLS
ARCH DERMATOL RES. 1981; 270(2): 230-231.
Web of Science
STINGL, G; GAZZE, LA; ABERER, W; WOLFF, K
LOSS OF ANTIGEN PRODUCTION AFTER UV-B-RADIATION
MED WELT. 1981; 32(17): 675-675.
Web of Science
STINGL, G; STINGLGAZZE, LA; ABERER, W; WOLFF, K
ULTRAVIOLET-B LIGHT-INDUCED IMPAIRMENT OF LANGERHANS CELL ANTIGEN-PRESENTING FUNCTION
CLIN RES. 1981; 29(2): A615-A615.
Web of Science
ABERER, W; SCHULER, G; STINGL, G; HONIGSMANN, H; WOLFF, D
LANGERHANS CELLS ARE PREFERENTIAL TARGET STRUCTURES OF EPIDERMAL UV DAMAGE
ARCH DERMATOL RES. 1980; 267(2): 212-212.
Web of Science
ABERER, W; SCHULER, G; STINGL, G; HONIGSMANN, H; WOLFF, K
EFFECTS OF UV-LIGHT ON EPIDERMAL LANGERHANS CELLS
J INVEST DERMATOL. 1980; 74(6): 458-458.
Web of Science